<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD000143" GROUP_ID="NEONATAL" ID="975499092720002951" MERGED_FROM="" MODIFIED="2009-02-13 20:16:39 +0100" MODIFIED_BY="Diane Haughton" NOTES="&lt;p&gt;Exported from Review Manager 4.2.10&lt;br&gt;Exported from Review Manager 4.3 Beta&lt;br&gt;Short title (no longer in use): Nasal CPAP after extubation in preterm infants&lt;/p&gt;&lt;p&gt;&lt;br&gt;do not remove&lt;/p&gt;&lt;p&gt;CL 2/03 update&lt;br&gt;sent to Loni to send to Davis Nov/06&lt;/p&gt;" NOTES_MODIFIED="2009-02-13 14:15:15 -0500" NOTES_MODIFIED_BY="[Empty name]" REVIEW_NO="1" REVMAN_SUB_VERSION="5.0.17" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="10.0">
<COVER_SHEET MODIFIED="2009-02-13 20:16:39 +0100" MODIFIED_BY="Diane Haughton">
<TITLE MODIFIED="2008-01-22 15:00:18 -0500" MODIFIED_BY="[Empty name]">Nasal continuous positive airway pressure immediately after extubation for preventing morbidity in preterm infants</TITLE>
<CONTACT MODIFIED="2009-02-13 20:16:39 +0100" MODIFIED_BY="Diane Haughton"><PERSON ID="17716" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Peter</FIRST_NAME><MIDDLE_INITIALS>G</MIDDLE_INITIALS><LAST_NAME>Davis</LAST_NAME><POSITION>Consultant Neonatologist</POSITION><EMAIL_1>pgd@unimelb.edu.au</EMAIL_1><ADDRESS><DEPARTMENT>Department of Paediatrics</DEPARTMENT><ORGANISATION>Royal Women's Hospital</ORGANISATION><ADDRESS_1>20 Flemington Rd</ADDRESS_1><CITY>Parkville</CITY><ZIP>3052</ZIP><REGION>Victoria</REGION><COUNTRY CODE="AU">Australia</COUNTRY><PHONE_1>+61 3 83453763</PHONE_1><FAX_1>+61 3 83453789</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2009-02-13 20:16:39 +0100" MODIFIED_BY="Diane Haughton"><PERSON ID="17716" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Peter</FIRST_NAME><MIDDLE_INITIALS>G</MIDDLE_INITIALS><LAST_NAME>Davis</LAST_NAME><POSITION>Consultant Neonatologist</POSITION><EMAIL_1>pgd@unimelb.edu.au</EMAIL_1><ADDRESS><DEPARTMENT>Department of Paediatrics</DEPARTMENT><ORGANISATION>Royal Women's Hospital</ORGANISATION><ADDRESS_1>20 Flemington Rd</ADDRESS_1><CITY>Parkville</CITY><ZIP>3052</ZIP><REGION>Victoria</REGION><COUNTRY CODE="AU">Australia</COUNTRY><PHONE_1>+61 3 83453763</PHONE_1><FAX_1>+61 3 83453789</FAX_1></ADDRESS></PERSON><PERSON ID="4691" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>David</FIRST_NAME><MIDDLE_INITIALS>J</MIDDLE_INITIALS><LAST_NAME>Henderson-Smart</LAST_NAME><POSITION>Director</POSITION><EMAIL_1>dhs@mail.usyd.edu.au</EMAIL_1><ADDRESS><DEPARTMENT>NSW Centre for Perinatal Health Services Research</DEPARTMENT><ORGANISATION>Queen Elizabeth II Research Institute</ORGANISATION><ADDRESS_1>Building DO2</ADDRESS_1><ADDRESS_2>University of Sydney</ADDRESS_2><CITY>Sydney</CITY><ZIP>2006</ZIP><REGION>NSW</REGION><COUNTRY CODE="AU">Australia</COUNTRY><PHONE_1>+61 2 93517318</PHONE_1><PHONE_2>+61 2 93517728</PHONE_2><FAX_1>+61 2 93517742</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2008-02-14 15:40:03 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Minor update: 14/12/07&lt;/p&gt;&lt;p&gt;New studies found and included or excluded: 22/11/02&lt;/p&gt;" NOTES_MODIFIED="2008-02-14 15:40:03 -0500" NOTES_MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="14" MONTH="12" YEAR="2007"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="27" MONTH="11" YEAR="2007"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="14" MONTH="12" YEAR="2009"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="1" YEAR="1997"/>
<REVIEW_PUBLISHED ISSUE="1" YEAR="1997"/>
<LAST_CITATION_ISSUE ISSUE="2" YEAR="2003"/>
</DATES>
<WHATS_NEW MODIFIED="2009-02-13 14:15:15 -0500" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-02-13 14:15:15 -0500" MODIFIED_BY="[Empty name]">
<DATE DAY="13" MONTH="2" YEAR="2009"/>
<DESCRIPTION>
<P>Updated contact details</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2009-02-13 14:15:04 -0500" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2009-02-13 14:15:04 -0500" MODIFIED_BY="[Empty name]">
<DATE DAY="11" MONTH="2" YEAR="2008"/>
<DESCRIPTION>
<P>This review updates the review "Nasal continuous positive airway pressure immediately after extubation for preventing morbidity in preterm infants" published in the Cochrane Database of Systematic Reviews, Issue 2, 2003 (Davis 2003).</P>
<P>One additional randomized trial has been included (Peake 2005).</P>
<P>The conclusions of the review are not altered by this study.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-02-13 14:15:01 -0500" MODIFIED_BY="[Empty name]">
<DATE DAY="17" MONTH="12" YEAR="2007"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS">
<DATE DAY="27" MONTH="11" YEAR="2007"/>
<DESCRIPTION>
<P>Substantive amendment</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>University of Melbourne</NAME>
<COUNTRY CODE="AU">Australia</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Centre for Perinatal Health Services Research, Sydney</NAME>
<COUNTRY CODE="AU">Australia</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Royal Women's Hospital, Melbourne</NAME>
<COUNTRY CODE="AU">Australia</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Murdoch Children's Research Institute, Melbourne</NAME>
<COUNTRY CODE="AU">Australia</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES>
<SOURCE>
<NAME>Department of Health and Aging, Commonwealth Government, Canberra</NAME>
<COUNTRY CODE="AU">Australia</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>National Health and Medical Research Council</NAME>
<COUNTRY CODE="AU">Australia</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2008-02-11 13:08:46 -0500" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2008-02-11 13:08:46 -0500" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2008-01-18 13:37:12 -0500" MODIFIED_BY="[Empty name]">Nasal continuous positive airways pressure immediately after extubation for preventing morbidity in preterm infants</TITLE>
<SUMMARY_BODY MODIFIED="2008-02-11 13:08:46 -0500" MODIFIED_BY="[Empty name]">
<P>Continuous positive airway pressure (CPAP) provides extra gas flow through the nose and thereby helps keep the lung properly inflated. This helps reduce breathing problems in preterm babies after the tube used to assist breathing is removed from their windpipe. Preterm babies (babies born before 37 weeks) may need help to breathe properly. Sometimes this is given via a tube placed into the windpipe, through the mouth or nose, to give oxygen from a machine (mechanical ventilation). This method helps restore breathing but when the tube is removed (this process of removal is called extubation), breathing problems can occur. Nasal continuous positive airways pressure (NCPAP) provides extra gas flow through the nose and thereby helps keep the lung properly inflated. The review of trials found NCPAP is effective in preventing failure of extubation after a period of mechanical ventilation.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2008-02-11 12:39:14 -0500" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND>
<P>Preterm infants being extubated following a period of intermittent positive pressure ventilation via an endotracheal tube are at risk of developing respiratory failure as a result of apnea, respiratory acidosis and hypoxia. Nasal continuous positive airway pressure appears to stabilise the upper airway, improve lung function and reduce apnea and may therefore have a role in facilitating extubation in this population.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2008-01-18 13:41:50 -0500" MODIFIED_BY="[Empty name]">
<P>To evaluate the effect of management with nasal continuous positive airways pressure (NCPAP) compared to extubation directly to headbox oxygen on the need for additional ventilatory support in preterm infants having their endotracheal tube removed following a period of intermittent positive pressure ventilation (IPPV),</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2008-02-11 12:39:14 -0500" MODIFIED_BY="[Empty name]">
<P>Searches were made of the Oxford Database of Perinatal Trials, PubMed up to November 2007, Cochrane Central Regsiter of Controlled Trials (The Cochrane Library, Issue 4, 2007), previous reviews including cross references, abstracts of conferences and symposia proceedings, expert informants and journal handsearching mainly in the English language.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2008-01-18 14:07:02 -0500" MODIFIED_BY="[Empty name]">
<P>All trials utilising random or quasi-random patient allocation, in which NCPAP (delivered by any method) was compared with headbox oxygen for post-extubation care were included. Methodological quality was assessed independently by the two review authors.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2008-01-18 13:43:57 -0500" MODIFIED_BY="[Empty name]">
<P>Data were extracted independently by the two review authors. Data were analysed using relative risk (RR), risk difference (RD) and number needed to treat (NNT).Prespecified subgroup analysis to determine the impact of different levels of NCPAP, differences in duration of IPPV and use of aminophylline were also performed.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2008-01-18 13:45:20 -0500" MODIFIED_BY="[Empty name]">
<P>When applied to preterm infants being extubated following IPPV, nasal CPAP reduces the incidence of respiratory failure (apnea, respiratory acidosis and increased oxygen requirements) indicating the need for additional ventilatory support [typical RR 0.62 (95% CI 0.51, 0.76), typical RD -0.17 (95% CI -0.23, -0.10), NNT 6 (4,10)].</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2008-01-18 13:45:39 -0500" MODIFIED_BY="[Empty name]">
<P>Implications for practice: nasal CPAP is effective in preventing failure of extubation in preterm infants following a period of endotracheal intubation and IPPV.</P>
<P>Implication for research: further definition of the gestational age and weight groups in whom these results apply is warranted. Optimal levels of NCPAP as well as methods of administration remain to be determined.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2008-02-11 12:47:28 -0500" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2008-01-18 13:46:04 -0500" MODIFIED_BY="[Empty name]">
<P>Preterm infants frequently receive intermittent positive pressure ventilation (IPPV) in the days following birth. Efforts to limit the duration of IPPV, and thereby minimise its attendant risk, lead to attempts at early weaning of ventilatory support and removal of the endotracheal tube. Failure to make the transition to spontaneous breathing following extubation is a common occurrence and may be due in part to a tendency towards alveolar atelectasis and to relatively poor respiratory drive, both characteristics of increasing prematurity. Clinical indications of respiratory failure post-extubation include: 1) apneic episodes [defined by the National Institute of Health (<LINK REF="REF-NIH-1987" TYPE="REFERENCE">NIH 1987</LINK>) as pauses greater than 20 seconds duration or shorter episodes associated with bradycardia, cyanosis or pallor] and 2) respiratory acidosis or 3) increasing oxygen requirements. These problems may lead to reintubation and ventilation with their attendant morbidity and economic costs.</P>
<P>Nasal continuous positive airways pressure (NCPAP) appears to stabilise the upper airway, improve lung function and reduce apnea. A number of randomised trials address the clinically important question of whether CPAP, applied prophylactically after extubation, reduces the need for additional ventilatory support.</P>
</BACKGROUND>
<OBJECTIVES MODIFIED="2008-01-18 13:46:53 -0500" MODIFIED_BY="[Empty name]">
<P>The main objective was to assess whether NCPAP, applied after extubation of preterm infants being weaned from IPPV, reduces the incidence of respiratory failure (as defined above) leading to the need for additional ventilatory support, without clinically important side effects. Additional ventilatory support comprised the reintroduction of endotracheal intubation for IPPV, or rescue therapy with NCPAP in infants failing initial treatment with headbox in trials where this was offered. The need for endotracheal reintubation alone was evaluated for all trials and also for the subset of trials in which rescue NCPAP was permitted.</P>
<P>In prespecified subgroups, analyses were conducted to determine whether the results differed for those infants:<BR/>1) also given methylxanthines<BR/>2) extubated in the first 14 days of life<BR/>3) given less than 5 cm H<SUB>2</SUB>0 CPAP compared with those given higher pressures<BR/>In <I>post hoc</I> subgroups, analyses were conducted to determine whether the results differed for those infants:<BR/>1) weighing less than 2000g</P>
</OBJECTIVES>
<METHODS>
<SELECTION_CRITERIA>
<CRIT_STUDIES>
<P>All trials utilising random or quasi-random patient allocation.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2008-01-18 13:47:19 -0500" MODIFIED_BY="[Empty name]">
<P>Preterm infants (infants &lt; 37 weeks gestation) being weaned from IPPV.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS>
<P>NCPAP compared with head box oxygen after extubation.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES>
<P>1) failure of extubation as defined by respiratory acidosis, increased oxygen requirement or apnea that is frequent or severe leading to additional ventilatory support;<BR/>2) the need for endotracheal reintubation <BR/>3) oxygen use at 28 days of age.</P>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2008-02-11 12:39:39 -0500" MODIFIED_BY="[Empty name]">
<P>Searches were made of the Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library, Issue 4, 2007), MEDLINE up to November 2007 (infant, continuous positive airway* pressure AND random*), previous reviews including cross references, abstracts, conferences and symposia proceedings of the Society for Pediatric Research and the European Society for Pediatric Research from 1993 - 2007, expert informants and journal handsearching mainly in the English language.</P>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2008-01-18 14:07:33 -0500" MODIFIED_BY="[Empty name]">
<P>Criteria and methods used to assess the methodological quality of the included trials: standard method of the Cochrane Collaboration and its Neonatal Review Group was used. Methodological quality of each trial was reviewed by the second review author blinded to trial authors and institutions. Additional information was requested from the authors of each trial to clarify methodology.</P>
<P>Methods used to collect data from the included trials: each review author extracted data separately before comparison and resolution of differences. Additional data requested from authors.</P>
<P>Methods used to synthesise data: The statistical analysis used a fixed effect model and calculated the relative risk (RR), risk difference (RD) and number needed to treat (NNT) with 95% confidence intervals.</P>
</DATA_COLLECTION>
</METHODS>
<RESULTS>
<STUDY_DESCRIPTION MODIFIED="2008-02-11 12:43:16 -0500" MODIFIED_BY="[Empty name]">
<P>Details are given in the table of included studies and in the reference list. Trials included; <LINK REF="STD-Engelke-1982" TYPE="STUDY">Engelke 1982;</LINK> <LINK REF="STD-Higgins-1991" TYPE="STUDY">Higgins 1991</LINK>; <LINK REF="STD-Chan-1993" TYPE="STUDY">Chan 1993</LINK>; <LINK REF="STD-So-1995" TYPE="STUDY">So 1995</LINK>; <LINK REF="STD-Annibale-1994" TYPE="STUDY">Annibale 1994</LINK>; <LINK REF="STD-Tapia-1995" TYPE="STUDY">Tapia 1995</LINK>; <LINK REF="STD-Davis-1998" TYPE="STUDY">Davis 1998</LINK>; <LINK REF="STD-Dimitriou-2000" TYPE="STUDY">Dimitriou 2000</LINK> and <LINK REF="STD-Peake-2005" TYPE="STUDY">Peake 2005</LINK>.</P>
<P>Four studies (<LINK REF="STD-Higgins-1991" TYPE="STUDY">Higgins 1991</LINK>; <LINK REF="STD-Engelke-1982" TYPE="STUDY">Engelke 1982</LINK>; <LINK REF="STD-Davis-1998" TYPE="STUDY">Davis 1998</LINK> and <LINK REF="STD-Dimitriou-2000" TYPE="STUDY">Dimitriou 2000</LINK>) allowed crossover from headbox to NCPAP if an infant was deemed to have failed. These infants were classified as treatment failures, even if they did not have IPPV reintroduced.</P>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2008-02-11 12:47:28 -0500" MODIFIED_BY="[Empty name]">
<P>Methodological quality was assessed using the criteria described in 'Effective Care of the Newborn Infant' (<LINK REF="REF-Sinclair-1992" TYPE="REFERENCE">Sinclair 1992</LINK>). Additional details of each study appear in the table of included studies.</P>
<P>
<B>
<I>Method of subject allocation:</I>
</B>
<BR/>All trials, with the exception of Tapia 1995, used random allocation for group assignment. Tapia used a method of quasi-random allocation, described as 'systematic sampling' which the author clarified as sequential case allocation. <LINK REF="STD-Chan-1993" TYPE="STUDY">Chan 1993</LINK>; <LINK REF="STD-Higgins-1991" TYPE="STUDY">Higgins 1991</LINK>; <LINK REF="STD-Engelke-1982" TYPE="STUDY">Engelke 1982</LINK>; <LINK REF="STD-Annibale-1994" TYPE="STUDY">Annibale 1994</LINK>; <LINK REF="STD-Davis-1998" TYPE="STUDY">Davis 1998</LINK>; <LINK REF="STD-Dimitriou-2000" TYPE="STUDY">Dimitriou 2000</LINK> and <LINK REF="STD-Peake-2005" TYPE="STUDY">Peake 2005</LINK> specified the use of sealed envelopes.</P>
<P>
<B>
<I>Masking of care-givers:</I>
</B>
<BR/>Because of the nature of the interventions, masking of group assignment was not undertaken. The care-givers were therefore aware of the group to which each infant was allocated and the possibility of co-intervention bias exists.</P>
<P>
<B>
<I>Completeness of outcome assessment:</I>
</B>
<BR/>This was achieved for all patients randomised in six of the studies. <LINK REF="STD-Tapia-1995" TYPE="STUDY">Tapia 1995</LINK> did not report the outcome in three of 90 patients because of 'accidental extubation'. Two of the 126 patients in Annibale's 1994 study were withdrawn, one at parents request and one following recognition of a predefined exclusion criterion. Outcome assessment was therefore complete or near complete in all studies.</P>
<P>
<B>
<I>Masking of outcome assessors:</I>
</B>
<BR/>The treatment method to which each baby was assigned was known to those assessing whether or not the baby met 'failure' criteria. Although the time period over which this was assessed varied from one day (<LINK REF="STD-Engelke-1982" TYPE="STUDY">Engelke 1982</LINK>) to seven days (<LINK REF="STD-Annibale-1994" TYPE="STUDY">Annibale 1994</LINK>; <LINK REF="STD-Davis-1998" TYPE="STUDY">Davis 1998</LINK> and <LINK REF="STD-Peake-2005" TYPE="STUDY">Peake 2005</LINK>), the criteria for failure were objective and consistent across the studies. These included respiratory acidosis (defined in terms of pH and pCO2), increased oxygen requirements or recurrent minor or single major apnoeic events. The use of such predetermined criteria addresses but does not eliminate the potential for bias in these unblinded trials. <LINK REF="STD-Annibale-1994" TYPE="STUDY">Annibale 1994</LINK> and <LINK REF="STD-Engelke-1982" TYPE="STUDY">Engelke 1982</LINK> included the less objective 'clinical deterioration' in their failure criteria. The other important outcome, assessed by <LINK REF="STD-Higgins-1991" TYPE="STUDY">Higgins 1991</LINK>; <LINK REF="STD-Annibale-1994" TYPE="STUDY">Annibale 1994</LINK>; <LINK REF="STD-So-1995" TYPE="STUDY">So 1995</LINK>; <LINK REF="STD-Davis-1998" TYPE="STUDY">Davis 1998</LINK> and <LINK REF="STD-Dimitriou-2000" TYPE="STUDY">Dimitriou 2000</LINK> was chronic lung disease, defined as oxygen dependency at 28 days of life. This assessment was also made in an unblinded manner.</P>
<P>The trial of <LINK REF="STD-Engelke-1982" TYPE="STUDY">Engelke 1982</LINK> had 18 participants, the other studies involved between 50 and 150 infants.</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2008-01-18 14:05:13 -0500" MODIFIED_BY="[Empty name]">
<P>Independent assignment of inclusion/exclusion status, methodological quality scores and data extraction resulted in no disagreement between the two reviewers.</P>
<P>
<B>PRIMARY OUTCOME<BR/>FAILURE (Outcome 01.01):</B>
<BR/>Infants extubated to NCPAP experience a reduction in respiratory failure leading to the need for additional ventilatory support [typical RR 0.62 (95% CI 0.51, 0.76), typical RD -0.17 (95% CI -0.23, -0.10)]. Hence treatment of 6 (95% CI 4,10) infants with NCPAP is required to prevent one extubation failure.</P>
<P>
<B>SECONDARY OUTCOMES<BR/>ENDOTRACHEAL REINTUBATION (Outcome 01.02):</B>
<BR/>The use of NCPAP as rescue therapy for infants failing headbox in 4 trials "dilutes" this effect for the outcome of need for endotracheal intubation. There is a trend towards a decreased requirement for endotracheal reintubation when NCPAP is used which does not reach statistical significance [typical RR 0.93 (95% CI 0.72, 1.19), typical RD -0.02 (95% CI -0.09, 0.05)].</P>
<P>
<B>OXYGEN USE AT 28 DAYS (01.03):</B>
<BR/>There was no significance difference in rates of oxygen use at 28 days of age in patients allocated to NCPAP in the five trials where this outcome was examined [typical RR 1.00 (95% CI 0.81, 1.24), typical RD 0.00 (95% CI -0.09, 0.09)].</P>
<P>
<B>SUBGROUP AND SENSITIVITY ANALYSES:</B>
<BR/>Exclusion of <LINK REF="STD-Engelke-1982" TYPE="STUDY">Engelke 1982</LINK>, in which the use of methylxanthines was avoided, does not substantially alter the outcomes failure or oxygen use at 28 days (Outcomes 02.01, 02.02) .</P>
<P>If analysis is restricted to those infants who were extubated in the first 14 days of life (Outcomes 03.01, 03.02), there is also a reduction in failure of extubation in the NCPAP group [typical RR 0.58 (95% CI 0.44, 0.75), typical RD -0.19 (95% CI -0.27, -0.10)] but no significant difference in oxygen use at 28 days of age [typical RR 1.17 (95% CI 0.91, 1.50), typical RD 0.06 (95% CI -0.03, 0.16)]. Pooled analysis of the 2 trials (66 infants) in which infants were extubated after 14 days (Outcome 04.01) showed no significant difference in failure of extubation [typical RR 1.12 (0.58, 2.15), typical RD 0.04 (95% CI -0.19, 0.27)].</P>
<P>While no direct comparison has been made between different levels of NCPAP, it is notable that in the two trials using levels less than 5 cm H<SUB>2</SUB>0 pressure (Outcome 05.01) no significant difference in failure rate was demonstrated [typical RR 1.09 (95% CI 0.69, 1.73), typical RD 0.02 (95% CI -0.10, 0.15)] whereas in trials permitting levels of 5 cm H<SUB>2</SUB>0 and above (Outcome 06.01), there was a significant result favouring NCPAP [typical RR 0.49 (95% CI 0.37, 0.66), typical RD -0.29 (95% CI -0.40, -0.19), NNT 3 (3, 5)] . <LINK REF="STD-Dimitriou-2000" TYPE="STUDY">Dimitriou 2000</LINK> and <LINK REF="STD-Peake-2005" TYPE="STUDY">Peake 2005</LINK> were not included in this subanalysis as the CPAP level administered (95% CI 3 to 5 cm H<SUB>2</SUB>0) included the predefined cutpoint.</P>
<P>In the four trials allowing rescue of infants failing on headbox (Outcome 07.01), there was no significant difference in requirement for endotracheal reintubation [typical RR 1.04 (95% CI 0.70, 1.53), typical RD 0.01 (95% CI -0.08, 0.10)].</P>
<P>Secondary analysis of the studies excluding that of Tapia (on the basis that patient allocation was not truly random) strengthens the conclusion that extubation to NCPAP leads to a lower 'failure' rate than extubation to headbox oxygen [typical RR 0.57 (95% CI 0.46, 0.72), typical RD -0.20 (95% CI -0.28, -0.13), NNT 5 (95% CI 4,8]. Excluding this study reduces but does not remove the heterogeneity apparent in the meta-analysis (OUTCOMES 08.01, 08.02).</P>
<P>Two studies included infants of birthweight more than 2kg (<LINK REF="STD-Dimitriou-2000" TYPE="STUDY">Dimitriou 2000</LINK> and <LINK REF="STD-Engelke-1982" TYPE="STUDY">Engelke 1982</LINK>). Exclusion of these studies did not substantially alter the outcomes failure or oxygen use at 28 days (Outcomes 09.01, 09.02).</P>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2008-01-18 13:55:55 -0500" MODIFIED_BY="[Empty name]">
<P>Although results varied from trial to trial, there is a clinically important advantage for infants extubated to nasal CPAP. The heterogeneity apparent in the overall analysis can be partly explained by the prespecified subgroup analysis into trials that used higher or lower levels of pressure. However, in the absence of trials directly comparing level of NCPAP, caution should be exercised in the interpretation of these findings.</P>
<P>The mechanism of action of NCPAP is uncertain but could be one or more of the following: maintenance of lung volume, ensuring maximum upper airway patency or airflow stimulation of the nose or upper airway, decreasing apnea of prematurity.</P>
<P>It may be anticipated that the benefits of NCPAP might vary between infants of differing weights and degrees of immaturity. Subgroup analysis of the studies involving infants weighing less than 2000g shows the same advantage of NCPAP. Further refinement of weight and gestational age specific recommendations could be undertaken in future trials.</P>
<P>Sensitivity analysis, including only the trials that permitted rescue therapy for infants failing headbox treatment, raises the question of whether the delayed use of NCPAP confers any disadvantage to infants allocated to headbox. It may be argued that the stability afforded by NCPAP, that is the prevention of failure criteria (apnea, increased oxygen requirements, respiratory acidosis), make it the desirable form of initial postextubation care. However there is no statistically significant difference in rates of endotracheal reintubation [typical RR 1.04 (95% CI 0.70, 1.53), typical RD 0.01 (95% CI -0.08, 0.10)]. Robertson (1998) compared "elective" with rescue NCPAP after extubation and concluded that rescue therapy could be safely used because there were no differences in number of ventilator days, days on CPAP or rates of successful extubation. Individual units, particularly those with limited resources, may use these findings to justify a policy of having infants "earn" their NCPAP.</P>
<P>The appropriate duration of treatment with NCPAP remains uncertain, as does the method of its weaning. There was heterogeneity across studies with respect to method of delivery of NCPAP. Direct comparison of different methods of delivery should be undertaken in future studies.</P>
</DISCUSSION>
<CONCLUSIONS>
<IMPLICATIONS_PRACTICE MODIFIED="2008-01-18 14:05:23 -0500" MODIFIED_BY="[Empty name]">
<P>NCPAP is effective in preventing respiratory failure in preterm infants following a period of endotracheal intubation and IPPV but does not influence the rate of supplemental oxygen dependency at 28 days of age. NCPAP of 5 cm H<SUB>2</SUB>0 or more appears to be more effective than NCPAP at lower pressures, although direct comparison has not been made.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH>
<P>Further definition of the gestational age and weight groups in whom these results apply is required. Optimal levels of nasal CPAP as well as methods and duration of administration remain to be determined.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS>
<P>Additional information was kindly provided by Prof. Anne Greenough for the Chan 1993 trial, Dr Tapia for the Tapia 1995 trial and Dr Dimitriou for the Dimitriou 2000 trial.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>Peter Davis is first author of a trial included in this review.<BR/> </P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2008-01-18 14:07:58 -0500" MODIFIED_BY="[Empty name]">
<P>Both review authors performed the literature search and extracted data independently. Differences at all stages were resolved by discussion. PD wrote the text of the review with editorial assistance from DHS.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2008-02-11 13:33:55 -0500" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2008-02-11 13:33:55 -0500" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2008-02-11 13:04:40 -0500" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Annibale-1994" MODIFIED="2008-02-11 13:00:25 -0500" MODIFIED_BY="[Empty name]" NAME="Annibale 1994" YEAR="1994">
<REFERENCE MODIFIED="2008-02-11 13:00:25 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Annibale D, Hulsey T, Engstrom P, Wallin L, Ohning B. Randomised, controlled trial of nasopharyngeal continuous positive airways pressure in the extubation of very low birthweight infants. J Pediatr 1994, 124:455-60.&lt;/p&gt;" NOTES_MODIFIED="2008-02-11 13:00:25 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Annibale D, Hulsey T, Engstrom P, Wallin L, Ohning B</AU>
<TI>Randomised, controlled trial of nasopharyngeal continuous positive airways pressure in the extubation of very low birthweight infants</TI>
<SO>Journal of Pediatrics</SO>
<YR>1994</YR>
<VL>124</VL>
<PG>455-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chan-1993" MODIFIED="2008-02-11 13:00:43 -0500" MODIFIED_BY="[Empty name]" NAME="Chan 1993" YEAR="1993">
<REFERENCE MODIFIED="2008-02-11 13:00:43 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Chan V, Greenough A. Randomised trial of methods of extubation in acute and chronic respiratory distress. Arch Dis Child 1993; 68:570-572.&lt;/p&gt;" NOTES_MODIFIED="2008-02-11 13:00:43 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chan V, Greenough A</AU>
<TI>Randomised trial of methods of extubation in acute and chronic respiratory distress</TI>
<SO>Archive of Disease in Childhood</SO>
<YR>1993</YR>
<VL>68</VL>
<PG>570-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Davis-1998" MODIFIED="2008-02-11 13:01:31 -0500" MODIFIED_BY="[Empty name]" NAME="Davis 1998" YEAR="1998">
<REFERENCE MODIFIED="2008-02-11 13:01:31 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Davis P, Jankov R, Doyle L, Henschke P</AU>
<TI>Randomised, controlled trial of nasal continuous positive airway pressure in the extubation of infants weighing 600 to 1250g</TI>
<SO>Archives of Disease in Childhood. Fetal and Neonatal Edition</SO>
<YR>1998</YR>
<VL>79</VL>
<PG>F54-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dimitriou-2000" MODIFIED="2008-02-11 13:03:16 -0500" MODIFIED_BY="[Empty name]" NAME="Dimitriou 2000" YEAR="2000">
<REFERENCE MODIFIED="2008-02-11 13:03:16 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dimitriou G, Greenough A, Kavvadia V, Laubscher, Alexiou C, Pavlou V, Mantagos S</AU>
<TI>Elective use of nasal continuous positive airways pressure following extubation of preterm infants</TI>
<SO>European Journal of Pediatrics</SO>
<YR>2000</YR>
<VL>159</VL>
<PG>434-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Engelke-1982" MODIFIED="2008-02-11 13:03:39 -0500" MODIFIED_BY="[Empty name]" NAME="Engelke 1982" YEAR="1982">
<REFERENCE MODIFIED="2008-02-11 13:03:39 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Engelke SC, Roloff DW, Kuhns LR. Postextubation nasal continuous positive airway pressure. Amer J Dis Child 1982, 136:359-361.&lt;br&gt;&lt;/p&gt;" NOTES_MODIFIED="2008-02-11 13:03:39 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Engelke SC, Roloff DW, Kuhns LR</AU>
<TI>Postextubation nasal continuous positive airway pressure</TI>
<SO>American Journal of Diseases of Children</SO>
<YR>1982</YR>
<VL>136</VL>
<PG>359-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Higgins-1991" NAME="Higgins 1991" YEAR="1991">
<REFERENCE NOTES="&lt;p&gt;Higgins RD, Richter SE, Davis JM. Nasal continuous positive pressure facilitates extubation of very low birthweight neonates. Pediatrics 1991, 88:999-1003.&lt;br&gt;&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Higgins RD, Richter SE, Davis JM</AU>
<TI>Nasal continuous positive pressure facilitates extubation of very low birthweight neonates</TI>
<SO>Pediatrics</SO>
<YR>1991</YR>
<VL>88</VL>
<PG>999-1003</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Peake-2005" MODIFIED="2008-02-11 13:03:54 -0500" MODIFIED_BY="[Empty name]" NAME="Peake 2005" YEAR="2005">
<REFERENCE MODIFIED="2008-02-11 13:03:54 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Peake M, Dillon P, Shaw NJ</AU>
<TI>Randomized trial of continuous positive airways pressure to prevent reventilation in preterm infants</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2005</YR>
<VL>39</VL>
<PG>247-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-So-1995" MODIFIED="2008-02-11 13:04:16 -0500" MODIFIED_BY="[Empty name]" NAME="So 1995" YEAR="1995">
<REFERENCE MODIFIED="2008-02-11 13:04:16 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;So B-H, Tamura M, Mishina J, Watanabe T, Kamoshita S. Application of nasal continuous positive airway pressure to early extubation in very low birthweight infants. Arch Dis Child 1995, 72:F191-193.&lt;/p&gt;" NOTES_MODIFIED="2008-02-11 13:04:16 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>So B-H, Tamura M, Mishina J, Watanabe T, Kamoshita S</AU>
<TI>Application of nasal continuous positive airway pressure to early extubation in very low birthweight infants</TI>
<SO>Archives of Disease in Childhood</SO>
<YR>1995</YR>
<VL>72</VL>
<PG>F191-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tapia-1995" MODIFIED="2008-02-11 13:04:40 -0500" MODIFIED_BY="[Empty name]" NAME="Tapia 1995" YEAR="1995">
<REFERENCE MODIFIED="2008-02-11 13:04:40 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Tapia J, Bancalari A, Gonzalez A, Mercado M. Does continuous positive airways pressure (CPAP) during weaning from intermittent mandatory ventilation in very low birthweight infants have risks or benefits? A controlled trial. Ped Pulm 1995, 19:269-279.&lt;/p&gt;" NOTES_MODIFIED="2008-02-11 13:04:40 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tapia J, Bancalari A, Gonzalez A, Mercado M</AU>
<TI>Does continuous positive airways pressure (CPAP) during weaning from intermittent mandatory ventilation in very low birthweight infants have risks or benefits? A controlled trial</TI>
<SO>Pediatric Pulmonology</SO>
<YR>1995</YR>
<VL>19</VL>
<PG>269-79</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2008-02-11 13:33:55 -0500" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Andreasson-1988" MODIFIED="2008-02-11 13:05:10 -0500" MODIFIED_BY="[Empty name]" NAME="Andreasson 1988" YEAR="1988">
<REFERENCE MODIFIED="2008-02-11 13:05:10 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Andreasson B, Lindroth M, Svenningsen NW, Jonson B. Effects on respiration of CPAP immediately after extubation in the very preterm infant. Pediatr Pulmon 1988, 4:213-218.&lt;/p&gt;" NOTES_MODIFIED="2008-02-11 13:05:10 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Andreasson B, Lindroth M, Svenningsen NW, Jonson B</AU>
<TI>Effects on respiration of CPAP immediately after extubation in the very preterm infant</TI>
<SO>Pediatric Pulmonology</SO>
<YR>1988</YR>
<VL>4</VL>
<PG>213-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Robertson-1998" MODIFIED="2008-02-11 13:33:55 -0500" MODIFIED_BY="[Empty name]" NAME="Robertson 1998" YEAR="">
<REFERENCE MODIFIED="2008-02-11 13:05:39 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Robertson NJ and Hamilton PA</AU>
<TI>Randomised trial of elective continuous positive airway pressure (CPAP) compared with rescue CPAP after extubation</TI>
<SO>Archives of Disease in Childhood. Fetal and Neonatal Edition</SO>
<YR>1998</YR>
<VL>79</VL>
<PG>F61-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2008-02-11 13:17:42 -0500" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2008-02-11 13:06:17 -0500" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-NIH-1987" MODIFIED="2008-02-11 13:06:17 -0500" MODIFIED_BY="[Empty name]" NAME="NIH 1987" TYPE="JOURNAL_ARTICLE">
<AU>National Institutes of Health</AU>
<TI>National Institutes of Health Consensus Development Conference on Infantile Apnea and Home Monitoring</TI>
<SO>Pediatrics</SO>
<YR>1987</YR>
<PG>292 -9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sinclair-1992" NAME="Sinclair 1992" NOTES="&lt;p&gt;Sinclair JC, Bracken MB (Eds.) Effective care of the newborn infant. Oxford University Press, Oxford, 1992&lt;br&gt;&lt;/p&gt;" TYPE="BOOK">
<AU>Sinclair JC, Bracken MB, editors</AU>
<SO>Effective care of the newborn infant</SO>
<YR>1992</YR>
<PB>Oxford University Press</PB>
<CY>Oxford</CY>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2008-02-11 13:17:42 -0500" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Davis-1997" MODIFIED="2008-02-11 13:06:42 -0500" MODIFIED_BY="[Empty name]" NAME="Davis 1997" TYPE="COCHRANE_REVIEW">
<AU>Davis PG, Henderson-Smart DJ</AU>
<TI>Nasal continuous positive airways pressure immediately after extubation for preventing morbidity in preterm infants</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>1997</YR>
<NO>1</NO>
<PB>Update Software</PB>
<CY>Oxford</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Davis-2000" MODIFIED="2008-02-11 13:07:18 -0500" MODIFIED_BY="[Empty name]" NAME="Davis 2000" TYPE="COCHRANE_REVIEW">
<AU>Davis PG, Henderson-Smart DJ</AU>
<TI>Nasal continuous positive airways pressure immediately after extubation for preventing morbidity in preterm infants</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2000</YR>
<NO>3</NO>
<PB>Update Software</PB>
<CY>Oxford</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Davis-2003" MODIFIED="2008-02-11 13:17:42 -0500" MODIFIED_BY="[Empty name]" NAME="Davis 2003" TYPE="COCHRANE_REVIEW">
<AU>Davis PG, Henderson-Smart DJ</AU>
<TI>Nasal continuous positive airways pressure immediately after extubation for preventing morbidity in preterm infants</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2003</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2008-02-11 13:15:43 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="DOI" VALUE=""/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2008-02-11 13:38:49 -0500" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2008-01-18 14:06:25 -0500" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR STUDY_ID="STD-Annibale-1994">
<CHAR_METHODS>
<P>Random allocation by opaque sealed envelopes, using random number table. Stratification by birth-weight (3 groups) and surfactant usage to give 6 strata.<BR/>Blinding of intervention and outcome assessment not attempted.<BR/>Adequate followup.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Eligible if birth weight 600 to 1500 g, endotracheal intubation within 48 hours of life, eligible for extubation by day 14 of life and stable or improving clinical course. Excluded if chromosomal anomalies, neuromuscular diseases, congenital anomalies or other surgical conditions.<BR/>Number enrolled = 82.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Three treatment regimens: 1) nasopharyngeal CPAP at 6 cm water until reached (defined) goal criteria, 2) nasopharyngeal CPAP for 6 hours then headbox oxygen and 3) headbox oxygen</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Success defined as the ability to remain free of the need for mechanical ventilation for 7 days after extubation and the achievement of specified goal criteria. Failure defined as an oxygen requirement of 80% or more, pH &lt; 7.20, severe apnea and bradycardia or clinical deterioration. CLD defined as oxygen use at 28 days.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Extubation from low rate ventilation.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Chan-1993">
<CHAR_METHODS>
<P>Randomised using sealed envelopes.<BR/>Blinding of intervention and outcome assessment not attempted.<BR/>Adequate followup.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Ventilated infants less than 1800g with no congenital abnormalities. Stratified into 2 groups: postnatal age less than 14 days or greater than or equal to 14 days.<BR/>Number enrolled = 120.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>NCPAP of 3 cm water or headbox oxygen</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Success defined as not requiring reintubation for 48 hours after extubation. Criteria for reintubation - ph &lt; 7.25 with pCO2 &gt;6.67 kPa, inspired oxygen &gt;60% or recurrent minor or one major apnea.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Aminophylline load given. Extubated after 1 hour ETT CPAP.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Davis-1998">
<CHAR_METHODS>
<P>Random allocation using sequentially numbered, sealed, opaque envelopes using a random number table. Stratified by gender, birthweight and postnatal age giving 8 strata.<BR/>Blinding of intervention and outcome assessment not attempted.<BR/>Adequate followup.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Inclusion criteria: inborn and outborn infants admitted to a single centre with<BR/>1) birthweight 600 to 1250 g<BR/>2) endotracheal tube for &gt; 12 hours<BR/>3) stable or improving respiratory status - ventilator rate &lt; 20/minute and inspired oxygen requirement &lt; 50%.<BR/>Number enrolled = 92.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Allocated to receive either nasal CPAP, set at 7 cm water, via a size 2.5 or 3.0 Portex tube inserted 2.5 cm into one nostril and connected to a Bear Cub ventilator or headbox oxygen</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Successful extubation determined over 7 days postextubation. Failure criteria comprised apnea (recurrent minor or 1 major), increased oxygen requirement (&gt;15% absolute increase above that required pre-extubation or respiratory acidosis (pH&lt;7.25 with pCO2&gt;50 mm Hg)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Extubated from low rate ventilation after loading with aminophylline. Trial stopped early after second planned interim analysis demonstrated significant benefit to NCPAP group using the O'Brien -Fleming stopping rule.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Dimitriou-2000">
<CHAR_METHODS>
<P>Random allocation using sequentially numbered, sealed opaque envelopes.<BR/>Blinding of intervention and outcome assessment not attempted.<BR/>Adequate followup.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Included inborn and outborn infants considered by the clinician to be ready for extubation. Gestational age less than or equal to 34 weeks and postnatal age less than or equal to 14 days. Methylxanthines were commenced universally before extubation. <BR/>Number enrolled = 150.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Allocated to receive either nasal CPAP, set at 3 to 5 cm water or headbox oxygen. CPAP provided either by single prong (n=40), Argyle prongs (n=22) or Flow Driver prongs (n=13) depending on availability in individual units.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Successful extubation determined over 48 hours post extubation. Failure criteria comprised oxygen requirement &gt; 60%, respiratory acidosis (pH&lt;7.25) and one major or frequent minor apnoeic episodes.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Extubation occurred after a period of endotracheal CPAP up to one hour.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-01-18 14:05:40 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Engelke-1982">
<CHAR_METHODS>
<P>Random allocation using shuffled envelopes.<BR/>Blinding of intervention and outcome assessment not attempted.<BR/>Adequate followup.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Inclusion criteria - all neonates intubated for more than 72 hours but less than 14 days.<BR/>Exclusion criteria - multiple or traumatic intubations, tracheal stenosis, chronic lung changes, neurological conditions, congestive heart failure, birthweight less than 1.0 kg, surgical conditions or major congenital anomalies.<BR/>Enrolled 18 infants, mean birthweight 2 kg and mean duration of ventilation 6 days.<BR/>Number enrolled = 18.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-01-18 14:05:40 -0500" MODIFIED_BY="[Empty name]">
<P>Allocated to either NCPAP at 6 cm H<SUB>2</SUB>O or headbox oxygen.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Extubation failure defined as 1) progressive atelectasis and respiratory distress, 2) pCO2 &gt; 60 mm Hg with pH &lt; 7.20, or increased oxygen requirement by &gt;0.15 - 0.20. Crossover from hood to NCPAP allowed.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>This study performed in the presurfactant era and the use of aminophylline was 'avoided'. Enrolment was discontinued after 18 patients because of 'considerably better' postextubation courses in the CPAP group.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-01-18 14:06:08 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Higgins-1991">
<CHAR_METHODS>
<P>Random allocation using sealed envelopes.<BR/>Blinding of intervention and outcome assessment not attempted.<BR/>Adequate followup.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-01-18 14:05:52 -0500" MODIFIED_BY="[Empty name]">
<P>Infants weighing &lt; 1 kg at time of first elective extubation. Intubated at least 24 hours, requiring &lt; 35% oxygen, MAP &lt;7 cm H<SUB>2</SUB>O, ventilator rate &lt; 20 breaths per minute and weight at least 80% of birth-weight.<BR/>Number enrolled = 58.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-01-18 14:06:08 -0500" MODIFIED_BY="[Empty name]">
<P>Silicone binasal pharyngeal airway prongs using 4 to 6 cm H<SUB>2</SUB>O of NCPAP or headbox oxygen</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Success defined as requiring no additional respiratory support for at least 5 days. Failure criteria: FiO2 &gt;0.60 to maintain oxygen saturations &gt; 93%, pCO2 &gt;60 or pH &lt;7.23, or moderate to severe apnea (defined). CLD defined as oxygen use at 28 days.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Peake-2005">
<CHAR_METHODS>
<P>Random allocation using consecutively numbered, sealed envelopes. Blinding of intervention and outcome assessment not attempted.<BR/>Adequate followup.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Inclusion criteria: infants born &lt;32 weeks gestation, ventilated via an ETT during the first 28 days of life and being extubated for the first time.<BR/>Excluded: Major congenital, cardiovascular or neuromuscular abnormalities. Median (range) birthweights: CPAP 1012g (640-1474), headbox 1105 (574-1670).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>CPAP: level set at 4-6 cm water via Infant Flow Driver. CPAP stopped after 24 hours and interrupted every 6-8 hours for a 1 hour break off CPAP.<BR/>Headbox oxygen: Humidified oxygen delivered to keep saturations in a prescribed (not specified range).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Successful extubation defined as not requiring reintubation for 7 days after removal of ETT. Failure criteria were any of pH &lt;7.25 on 2 consecutive blood gases, pCO2 &gt;55 mmHg on 2 consecutive blood gases, Inspired oxygen at or above 0.7 and 3 or more episodes of apnea requiring stimulation or 1 requiring IPPV.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>All infants received at least 1 dose of surfactant. All infants were commenced on methylxanthine therapy when the ventilator rate was &lt;40/min. Headbox oxygen was the preferred treatment before the trial. In the case of reintubation, subsequent extubations of infants in both groups were managed with headbox oxygen.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-So-1995">
<CHAR_METHODS>
<P>Random allocation.<BR/>Blinding of intervention and outcome assessment not attempted.<BR/>Adequate followup.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Birth weight &lt; 1500g, GA &lt; 34 weeks, mechanical ventilation within first few hours of life, weaning started within 7 days of life, absence of overwhelming infection and congenital abnormalities.<BR/>Number enrolled = 50.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Single prong NCPAP at 5 cm water or headbox oxygen</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Success defined as reintubation not required for 72 hours after extubation. Reintubation if pO2 &lt;50 mm Hg with FiO2 &gt;70%, pH &lt;7.25 and pCO2 &gt;60, severe or frequent apnea. CLD defined as oxygen use at 28 days with an abnormal chest xray.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Aminophylline load given. Extubation from ETT CPAP.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-01-18 14:06:25 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tapia-1995">
<CHAR_METHODS>
<P>Assigned by alternate case.<BR/>Blinding of intervention and outcome assessment not attempted.<BR/>Adequate followup.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Preterm infants &lt; 1500g requiring ventilation for more than 48 hours. Criteria for entry: FiO2 &lt;0.40, rate &lt; 20/min, peak pressure &lt; 15 cm water. Excluded infants with sepsis, PDA, NEC, grade 3 or 4 IVH or other severe neurological damage.<BR/>Number enrolled = 59.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-01-18 14:06:25 -0500" MODIFIED_BY="[Empty name]">
<P>Three groups: 1) direct extubation to headbox oxygen<BR/>2) pre-extubation ETT CPAP (3 to 4 cm H<SUB>2</SUB>O) for 12 -24 hours<BR/>3) Postextubation nasopharyngeal CPAP (3 to 4 cm H<SUB>2</SUB>O) for 12 - 24 hours.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Failure defined as need to return to mechanical ventilation within 72 hours of extubation because of either 1) frequent or severe apnea, 2) pH &lt; 7.25 and pCO2 &gt;60 mm Hg or 3)FiO2 &gt;0.60</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Extubated from low rate ventilation. Loaded with aminophylline.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>ETT = endotracheal tube NCPAP = nasal continuous positive airway pressure PDA = patent ductus arteriosus IVH = intraventicular hemorrhage</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2008-02-11 13:38:49 -0500" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Andreasson-1988">
<CHAR_REASON_FOR_EXCLUSION>
<P>This well conducted cross-over trial evaluated the short term benefits of CPAP administered via a face-mask. Infants experienced less apnea and were better oxygenated during their 10 minute trial periods of CPAP. This study was not included because it did not address the issues of longer term therapy with NCPAP vs headbox.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-02-11 13:38:49 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Robertson-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-02-11 13:38:49 -0500" MODIFIED_BY="[Empty name]">
<P>This randomised trial compared two strategies of postextubation delivery of CPAP: weaning vs rescue. The criteria for rescue CPAP were set "lower" than those for endotracheal reintubation. In fact, all or nearly all infants in the rescue group received CPAP. This differed from other included trials in which rescue of headbox infants was permitted. In these trials, infants were deemed to have reached reintubation criteria and counted as failures of therapy but could be tried on CPAP at the clinician's discretion. The question asked by Robertson is "does it matter when CPAP is started after extubation" rather than that posed by this review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Annibale-1994">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Chan-1993">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Davis-1998">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Dimitriou-2000">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Engelke-1982">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Higgins-1991">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Peake-2005">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-So-1995">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="NO" STUDY_ID="STD-Tapia-1995">
<DESCRIPTION>
<P>C - Inadequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2008-02-11 13:21:57 -0500" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" NO="1">
<NAME>Nasal CPAP vs Headbox</NAME>
<DICH_OUTCOME CHI2="17.928615288087773" CI_END="0.7623916107080727" CI_START="0.5076929487621047" CI_STUDY="95" CI_TOTAL="95" DF="8.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6221421420799849" ESTIMABLE="YES" EVENTS_1="99" EVENTS_2="159" I2="55.378595215240054" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="-0.11782189128268512" LOG_CI_START="-0.2943988683759235" LOG_EFFECT_SIZE="-0.20611037982930427" METHOD="MH" NO="1" P_CHI2="0.02176810708927579" P_Q="0.0" P_Z="4.749569505629788E-6" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="363" TOTAL_2="363" WEIGHT="99.99999999999999" Z="4.575555975137105">
<NAME>Failure</NAME>
<GROUP_LABEL_1>NCPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>Headbox</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NCPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Headbox</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.5941904334831003" CI_START="0.5384223445562102" EFFECT_SIZE="0.9264705882352942" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="17" LOG_CI_END="0.20254019866045836" LOG_CI_START="-0.26887692516576756" LOG_EFFECT_SIZE="-0.0331683632526546" ORDER="47" O_E="0.0" SE="0.2769127520879231" STUDY_ID="STD-Annibale-1994" TOTAL_1="40" TOTAL_2="42" VAR="0.07668067226890757" WEIGHT="10.373254537980735"/>
<DICH_DATA CI_END="1.422107786431701" CI_START="0.5244804758903293" EFFECT_SIZE="0.8636363636363636" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="22" LOG_CI_END="0.1529325143111046" LOG_CI_START="-0.2802706740498591" LOG_EFFECT_SIZE="-0.06366907986937727" ORDER="48" O_E="0.0" SE="0.2544656972335968" STUDY_ID="STD-Chan-1993" TOTAL_1="60" TOTAL_2="60" VAR="0.06475279106858055" WEIGHT="13.759817048909738"/>
<DICH_DATA CI_END="0.9023409125657522" CI_START="0.35675584707168095" EFFECT_SIZE="0.5673758865248227" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="27" LOG_CI_END="-0.04462935106774575" LOG_CI_START="-0.4476289002591268" LOG_EFFECT_SIZE="-0.24612912566343625" ORDER="49" O_E="0.0" SE="0.23672393007495873" STUDY_ID="STD-Davis-1998" TOTAL_1="47" TOTAL_2="45" VAR="0.056038219070133954" WEIGHT="17.25415793978899"/>
<DICH_DATA CI_END="1.0444974973385885" CI_START="0.3446633437775495" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="25" LOG_CI_END="0.01890740372911514" LOG_CI_START="-0.4626049029618279" LOG_EFFECT_SIZE="-0.22184874961635637" ORDER="50" O_E="0.0" SE="0.282842712474619" STUDY_ID="STD-Dimitriou-2000" TOTAL_1="75" TOTAL_2="75" VAR="0.07999999999999999" WEIGHT="15.63615573739743"/>
<DICH_DATA CI_END="1.1908760601251096" CI_START="0.004968745246832799" EFFECT_SIZE="0.07692307692307693" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="6" LOG_CI_END="0.07586656483740845" LOG_CI_START="-2.303753269451082" LOG_EFFECT_SIZE="-1.1139433523068367" ORDER="51" O_E="0.0" SE="1.3978004699692133" STUDY_ID="STD-Engelke-1982" TOTAL_1="9" TOTAL_2="9" VAR="1.9538461538461536" WEIGHT="4.065400491723332"/>
<DICH_DATA CI_END="0.5956426655046728" CI_START="0.15550867089981768" EFFECT_SIZE="0.30434782608695654" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="23" LOG_CI_END="-0.2250142015686075" LOG_CI_START="-0.8082453904380645" LOG_EFFECT_SIZE="-0.516629796003336" ORDER="52" O_E="0.0" SE="0.34259288738286553" STUDY_ID="STD-Higgins-1991" TOTAL_1="29" TOTAL_2="29" VAR="0.11736988648532877" WEIGHT="14.385263278405636"/>
<DICH_DATA CI_END="1.0677679183951514" CI_START="0.39942103109177673" EFFECT_SIZE="0.6530612244897959" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="24" LOG_CI_END="0.02847686812962176" LOG_CI_START="-0.3985690715468373" LOG_EFFECT_SIZE="-0.18504610170860772" ORDER="53" O_E="0.0" SE="0.25084889887744616" STUDY_ID="STD-Peake-2005" TOTAL_1="49" TOTAL_2="48" VAR="0.06292517006802721" WEIGHT="15.165459090457219"/>
<DICH_DATA CI_END="0.8148735481416008" CI_START="0.11618312611684649" EFFECT_SIZE="0.3076923076923077" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="13" LOG_CI_END="-0.08890977973258553" LOG_CI_START="-0.934856942225163" LOG_EFFECT_SIZE="-0.5118833609788743" ORDER="54" O_E="0.0" SE="0.49691355075412963" STUDY_ID="STD-So-1995" TOTAL_1="25" TOTAL_2="25" VAR="0.24692307692307694" WEIGHT="8.130800983446663"/>
<DICH_DATA CI_END="16.005522978132642" CI_START="0.8190543724802425" EFFECT_SIZE="3.6206896551724137" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="2" LOG_CI_END="1.2042698692209484" LOG_CI_START="-0.08668726687898436" LOG_EFFECT_SIZE="0.558791301170982" ORDER="55" O_E="0.0" SE="0.7583146120859863" STUDY_ID="STD-Tapia-1995" TOTAL_1="29" TOTAL_2="30" VAR="0.5750410509031199" WEIGHT="1.2296908918902387"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="14.219193422152538" CI_END="1.0849410334865266" CI_START="0.6943834652757356" CI_STUDY="95" CI_TOTAL="95" DF="8.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8679660790907743" ESTIMABLE="YES" EVENTS_1="99" EVENTS_2="114" I2="43.73801830744814" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="0.03540613493355699" LOG_CI_START="-0.15840062916941552" LOG_EFFECT_SIZE="-0.06149724711792926" METHOD="MH" NO="2" P_CHI2="0.07622814542913459" P_Q="0.0" P_Z="0.21355814979102972" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="363" TOTAL_2="363" WEIGHT="100.0" Z="1.243840895413333">
<NAME>Endotracheal reintubation</NAME>
<GROUP_LABEL_1>NCPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>Headbox</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NCPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Headbox</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.5941904334831003" CI_START="0.5384223445562102" EFFECT_SIZE="0.9264705882352942" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="17" LOG_CI_END="0.20254019866045836" LOG_CI_START="-0.26887692516576756" LOG_EFFECT_SIZE="-0.0331683632526546" ORDER="56" O_E="0.0" SE="0.2769127520879231" STUDY_ID="STD-Annibale-1994" TOTAL_1="40" TOTAL_2="42" VAR="0.07668067226890757" WEIGHT="14.47198712281442"/>
<DICH_DATA CI_END="1.422107786431701" CI_START="0.5244804758903293" EFFECT_SIZE="0.8636363636363636" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="22" LOG_CI_END="0.1529325143111046" LOG_CI_START="-0.2802706740498591" LOG_EFFECT_SIZE="-0.06366907986937727" ORDER="57" O_E="0.0" SE="0.2544656972335968" STUDY_ID="STD-Chan-1993" TOTAL_1="60" TOTAL_2="60" VAR="0.06475279106858055" WEIGHT="19.196665271733245"/>
<DICH_DATA CI_END="1.9727680138280648" CI_START="0.6069280198871702" EFFECT_SIZE="1.094224924012158" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="14" LOG_CI_END="0.2950760177215547" LOG_CI_START="-0.21686281208692879" LOG_EFFECT_SIZE="0.039106602817312944" ORDER="58" O_E="0.0" SE="0.3007154027675808" STUDY_ID="STD-Davis-1998" TOTAL_1="47" TOTAL_2="45" VAR="0.09042975346166834" WEIGHT="12.481626233992564"/>
<DICH_DATA CI_END="3.5705608027685374" CI_START="0.7779668044369803" EFFECT_SIZE="1.6666666666666667" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="9" LOG_CI_END="0.5527364330366169" LOG_CI_START="-0.1090389338039041" LOG_EFFECT_SIZE="0.22184874961635637" ORDER="59" O_E="0.0" SE="0.38873012632302" STUDY_ID="STD-Dimitriou-2000" TOTAL_1="75" TOTAL_2="75" VAR="0.15111111111111108" WEIGHT="7.853181247527236"/>
<DICH_DATA CI_END="3.6607149685994704" CI_START="0.01092682722995594" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5635659150646828" LOG_CI_START="-1.9615059237367205" LOG_EFFECT_SIZE="-0.6989700043360187" ORDER="60" O_E="0.0" SE="1.4832396974191324" STUDY_ID="STD-Engelke-1982" TOTAL_1="9" TOTAL_2="9" VAR="2.1999999999999997" WEIGHT="2.1814392354242322"/>
<DICH_DATA CI_END="1.410120390358691" CI_START="0.2871802155721906" EFFECT_SIZE="0.6363636363636364" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="11" LOG_CI_END="0.14925619253939076" LOG_CI_START="-0.5418454828273271" LOG_EFFECT_SIZE="-0.19629464514396822" ORDER="61" O_E="0.0" SE="0.4059565451188765" STUDY_ID="STD-Higgins-1991" TOTAL_1="29" TOTAL_2="29" VAR="0.16480071652485445" WEIGHT="9.598332635866623"/>
<DICH_DATA CI_END="1.0677679183951514" CI_START="0.39942103109177673" EFFECT_SIZE="0.6530612244897959" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="24" LOG_CI_END="0.02847686812962176" LOG_CI_START="-0.3985690715468373" LOG_EFFECT_SIZE="-0.18504610170860772" ORDER="62" O_E="0.0" SE="0.25084889887744616" STUDY_ID="STD-Peake-2005" TOTAL_1="49" TOTAL_2="48" VAR="0.06292517006802721" WEIGHT="21.157711677186782"/>
<DICH_DATA CI_END="0.8148735481416008" CI_START="0.11618312611684649" EFFECT_SIZE="0.3076923076923077" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="13" LOG_CI_END="-0.08890977973258553" LOG_CI_START="-0.934856942225163" LOG_EFFECT_SIZE="-0.5118833609788743" ORDER="63" O_E="0.0" SE="0.49691355075412963" STUDY_ID="STD-So-1995" TOTAL_1="25" TOTAL_2="25" VAR="0.24692307692307694" WEIGHT="11.343484024206008"/>
<DICH_DATA CI_END="16.005522978132642" CI_START="0.8190543724802425" EFFECT_SIZE="3.6206896551724137" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="2" LOG_CI_END="1.2042698692209484" LOG_CI_START="-0.08668726687898436" LOG_EFFECT_SIZE="0.558791301170982" ORDER="64" O_E="0.0" SE="0.7583146120859863" STUDY_ID="STD-Tapia-1995" TOTAL_1="29" TOTAL_2="30" VAR="0.5750410509031199" WEIGHT="1.715572551248888"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="12.574441411648948" CI_END="1.243905875153208" CI_START="0.808119329222671" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0026087878354897" ESTIMABLE="YES" EVENTS_1="92" EVENTS_2="92" I2="68.18944182845048" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="0.09478751906209623" LOG_CI_START="-0.09252450531884773" LOG_EFFECT_SIZE="0.00113150687162424" METHOD="MH" NO="3" P_CHI2="0.013553676825787009" P_Q="0.0" P_Z="0.9811083843044289" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="216" TOTAL_2="217" WEIGHT="100.0" Z="0.023679341718424295">
<NAME>Oxygen use at 28 days</NAME>
<GROUP_LABEL_1>NCPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>Headbox</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NCPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Headbox</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.3121500097843388" CI_START="0.4726260300847211" EFFECT_SIZE="0.7875" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="20" LOG_CI_END="0.11798348801023986" LOG_CI_START="-0.32548236308696366" LOG_EFFECT_SIZE="-0.1037494375383619" ORDER="65" O_E="0.0" SE="0.26049403612586386" STUDY_ID="STD-Annibale-1994" TOTAL_1="40" TOTAL_2="42" VAR="0.06785714285714287" WEIGHT="21.292384589185545"/>
<DICH_DATA CI_END="1.8347635475341042" CI_START="0.9076468905816681" EFFECT_SIZE="1.2904717853839038" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="23" LOG_CI_END="0.2635801031287629" LOG_CI_START="-0.042083075816150846" LOG_EFFECT_SIZE="0.11074851365630602" ORDER="66" O_E="0.0" SE="0.1795480643693804" STUDY_ID="STD-Davis-1998" TOTAL_1="47" TOTAL_2="45" VAR="0.03223750741879117" WEIGHT="25.64401568960034"/>
<DICH_DATA CI_END="2.2549339822400922" CI_START="0.9382547320685042" EFFECT_SIZE="1.4545454545454546" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="22" LOG_CI_END="0.3531338315494408" LOG_CI_START="-0.02767923655404132" LOG_EFFECT_SIZE="0.16272729749769974" ORDER="67" O_E="0.0" SE="0.2236914812590743" STUDY_ID="STD-Dimitriou-2000" TOTAL_1="75" TOTAL_2="75" VAR="0.050037878787878784" WEIGHT="24.0071636243067"/>
<DICH_DATA CI_END="0.8640747711677105" CI_START="0.30962441376377225" EFFECT_SIZE="0.5172413793103449" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="22" LOG_CI_END="-0.06344867499735926" LOG_CI_START="-0.5091648026891904" LOG_EFFECT_SIZE="-0.2863067388432748" ORDER="68" O_E="0.0" SE="0.2618158597365969" STUDY_ID="STD-Higgins-1991" TOTAL_1="29" TOTAL_2="30" VAR="0.06854754440961336" WEIGHT="23.60026254592862"/>
<DICH_DATA CI_END="2.2452542631126713" CI_START="0.160338187934635" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.35126552966630087" LOG_CI_START="-0.7949630288990137" LOG_EFFECT_SIZE="-0.22184874961635637" ORDER="69" O_E="0.0" SE="0.6733003292241385" STUDY_ID="STD-So-1995" TOTAL_1="25" TOTAL_2="25" VAR="0.45333333333333337" WEIGHT="5.456173550978796"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2008-02-11 13:21:57 -0500" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Nasal CPAP vs Headbox (methylxanthines given)</NAME>
<DICH_OUTCOME CHI2="15.588042809132526" CI_END="0.7914077273942601" CI_START="0.5260795267078892" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6452467765595877" ESTIMABLE="YES" EVENTS_1="99" EVENTS_2="153" I2="55.09378511650655" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="-0.10159971354901229" LOG_CI_START="-0.2789485991927681" LOG_EFFECT_SIZE="-0.1902741563708902" METHOD="MH" MODIFIED="2008-02-11 13:21:26 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.029158448902340872" P_Q="0.0" P_Z="2.6037409966147573E-5" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="354" TOTAL_2="354" WEIGHT="99.99999999999997" Z="4.205614174816978">
<NAME>Failure</NAME>
<GROUP_LABEL_1>NCPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>Headbox</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NCPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Headbox</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.5941904334831003" CI_START="0.5384223445562102" EFFECT_SIZE="0.9264705882352942" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="17" LOG_CI_END="0.20254019866045836" LOG_CI_START="-0.26887692516576756" LOG_EFFECT_SIZE="-0.0331683632526546" ORDER="70" O_E="0.0" SE="0.2769127520879231" STUDY_ID="STD-Annibale-1994" TOTAL_1="40" TOTAL_2="42" VAR="0.07668067226890757" WEIGHT="10.812839779547724"/>
<DICH_DATA CI_END="1.422107786431701" CI_START="0.5244804758903293" EFFECT_SIZE="0.8636363636363636" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="22" LOG_CI_END="0.1529325143111046" LOG_CI_START="-0.2802706740498591" LOG_EFFECT_SIZE="-0.06366907986937727" ORDER="71" O_E="0.0" SE="0.2544656972335968" STUDY_ID="STD-Chan-1993" TOTAL_1="60" TOTAL_2="60" VAR="0.06475279106858055" WEIGHT="14.342913942870657"/>
<DICH_DATA CI_END="0.9023409125657522" CI_START="0.35675584707168095" EFFECT_SIZE="0.5673758865248227" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="27" LOG_CI_END="-0.04462935106774575" LOG_CI_START="-0.4476289002591268" LOG_EFFECT_SIZE="-0.24612912566343625" ORDER="72" O_E="0.0" SE="0.23672393007495873" STUDY_ID="STD-Davis-1998" TOTAL_1="47" TOTAL_2="45" VAR="0.056038219070133954" WEIGHT="17.985333788046308"/>
<DICH_DATA CI_END="1.0444974973385885" CI_START="0.3446633437775495" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="25" LOG_CI_END="0.01890740372911514" LOG_CI_START="-0.4626049029618279" LOG_EFFECT_SIZE="-0.22184874961635637" ORDER="73" O_E="0.0" SE="0.282842712474619" STUDY_ID="STD-Dimitriou-2000" TOTAL_1="75" TOTAL_2="75" VAR="0.07999999999999999" WEIGHT="16.2987658441712"/>
<DICH_DATA CI_END="0.5956426655046728" CI_START="0.15550867089981768" EFFECT_SIZE="0.30434782608695654" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="23" LOG_CI_END="-0.2250142015686075" LOG_CI_START="-0.8082453904380645" LOG_EFFECT_SIZE="-0.516629796003336" ORDER="74" O_E="0.0" SE="0.34259288738286553" STUDY_ID="STD-Higgins-1991" TOTAL_1="29" TOTAL_2="29" VAR="0.11736988648532877" WEIGHT="14.994864576637505"/>
<DICH_DATA CI_END="1.0677679183951514" CI_START="0.39942103109177673" EFFECT_SIZE="0.6530612244897959" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="24" LOG_CI_END="0.02847686812962176" LOG_CI_START="-0.3985690715468373" LOG_EFFECT_SIZE="-0.18504610170860772" ORDER="75" O_E="0.0" SE="0.25084889887744616" STUDY_ID="STD-Peake-2005" TOTAL_1="49" TOTAL_2="48" VAR="0.06292517006802721" WEIGHT="15.80812258370749"/>
<DICH_DATA CI_END="0.8148735481416008" CI_START="0.11618312611684649" EFFECT_SIZE="0.3076923076923077" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="13" LOG_CI_END="-0.08890977973258553" LOG_CI_START="-0.934856942225163" LOG_EFFECT_SIZE="-0.5118833609788743" ORDER="76" O_E="0.0" SE="0.49691355075412963" STUDY_ID="STD-So-1995" TOTAL_1="25" TOTAL_2="25" VAR="0.24692307692307694" WEIGHT="8.475358238969024"/>
<DICH_DATA CI_END="16.005522978132642" CI_START="0.8190543724802425" EFFECT_SIZE="3.6206896551724137" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="2" LOG_CI_END="1.2042698692209484" LOG_CI_START="-0.08668726687898436" LOG_EFFECT_SIZE="0.558791301170982" ORDER="77" O_E="0.0" SE="0.7583146120859863" STUDY_ID="STD-Tapia-1995" TOTAL_1="29" TOTAL_2="30" VAR="0.5750410509031199" WEIGHT="1.281801246050074"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="9.281291356825376" CI_END="1.1017242480717815" CI_START="0.6710551738226768" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8598358894547652" ESTIMABLE="YES" EVENTS_1="60" EVENTS_2="70" I2="67.6769117069703" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="0.042072908012426" LOG_CI_START="-0.17324177088667403" LOG_EFFECT_SIZE="-0.06558443143712402" METHOD="MH" MODIFIED="2008-02-11 13:21:57 -0500" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.025775623058820862" P_Q="0.0" P_Z="0.23247704394243085" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="141" TOTAL_2="142" WEIGHT="100.00000000000001" Z="1.1940024174899564">
<NAME>Oxygen use at 28 days</NAME>
<GROUP_LABEL_1>NCPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>Headbox</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NCPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Headbox</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.3121500097843388" CI_START="0.4726260300847211" EFFECT_SIZE="0.7875" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="20" LOG_CI_END="0.11798348801023986" LOG_CI_START="-0.32548236308696366" LOG_EFFECT_SIZE="-0.1037494375383619" ORDER="78" O_E="0.0" SE="0.26049403612586386" STUDY_ID="STD-Annibale-1994" TOTAL_1="40" TOTAL_2="42" VAR="0.06785714285714287" WEIGHT="28.018936527017203"/>
<DICH_DATA CI_END="1.8347635475341042" CI_START="0.9076468905816681" EFFECT_SIZE="1.2904717853839038" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="23" LOG_CI_END="0.2635801031287629" LOG_CI_START="-0.042083075816150846" LOG_EFFECT_SIZE="0.11074851365630602" ORDER="79" O_E="0.0" SE="0.1795480643693804" STUDY_ID="STD-Davis-1998" TOTAL_1="47" TOTAL_2="45" VAR="0.03223750741879117" WEIGHT="33.74530667972634"/>
<DICH_DATA CI_END="0.8640747711677105" CI_START="0.30962441376377225" EFFECT_SIZE="0.5172413793103449" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="22" LOG_CI_END="-0.06344867499735926" LOG_CI_START="-0.5091648026891904" LOG_EFFECT_SIZE="-0.2863067388432748" ORDER="80" O_E="0.0" SE="0.2618158597365969" STUDY_ID="STD-Higgins-1991" TOTAL_1="29" TOTAL_2="30" VAR="0.06854754440961336" WEIGHT="31.055904308208305"/>
<DICH_DATA CI_END="2.2452542631126713" CI_START="0.160338187934635" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.35126552966630087" LOG_CI_START="-0.7949630288990137" LOG_EFFECT_SIZE="-0.22184874961635637" ORDER="81" O_E="0.0" SE="0.6733003292241385" STUDY_ID="STD-So-1995" TOTAL_1="25" TOTAL_2="25" VAR="0.45333333333333337" WEIGHT="7.179852485048158"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" NO="3">
<NAME>Nasal CPAP vs Headbox (extubation &lt; or = 14 days of age)</NAME>
<DICH_OUTCOME CHI2="6.664447720620721" CI_END="0.7523861643441602" CI_START="0.4413978091988544" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.576282573580914" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="98" I2="24.97502854543656" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="-0.12355919930484846" LOG_CI_START="-0.35516982671403224" LOG_EFFECT_SIZE="-0.23936451300944037" METHOD="MH" NO="1" P_CHI2="0.24681562089194986" P_Q="0.0" P_Z="5.096439789043994E-5" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="224" TOTAL_2="222" WEIGHT="100.00000000000001" Z="4.051159741013421">
<NAME>Failure</NAME>
<GROUP_LABEL_1>NCPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>Headbox</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NCPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Headbox</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.5941904334831003" CI_START="0.5384223445562102" EFFECT_SIZE="0.9264705882352942" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="17" LOG_CI_END="0.20254019866045836" LOG_CI_START="-0.26887692516576756" LOG_EFFECT_SIZE="-0.0331683632526546" ORDER="82" O_E="0.0" SE="0.2769127520879231" STUDY_ID="STD-Annibale-1994" TOTAL_1="40" TOTAL_2="42" VAR="0.07668067226890757" WEIGHT="16.718841574109813"/>
<DICH_DATA CI_END="1.265304116767002" CI_START="0.29929423277282047" EFFECT_SIZE="0.6153846153846154" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="13" LOG_CI_END="0.1021949210534825" LOG_CI_START="-0.5239016516832687" LOG_EFFECT_SIZE="-0.21085336531489315" ORDER="83" O_E="0.0" SE="0.36777222605358645" STUDY_ID="STD-Chan-1993" TOTAL_1="30" TOTAL_2="30" VAR="0.13525641025641028" WEIGHT="13.104621410294897"/>
<DICH_DATA CI_END="0.9266616462203544" CI_START="0.3499302864548829" EFFECT_SIZE="0.5694444444444444" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="24" LOG_CI_END="-0.03307881170594202" LOG_CI_START="-0.45601846771712395" LOG_EFFECT_SIZE="-0.24454863971153298" ORDER="84" O_E="0.0" SE="0.24843684752603043" STUDY_ID="STD-Davis-1998" TOTAL_1="45" TOTAL_2="41" VAR="0.061720867208672085" WEIGHT="25.318409880355077"/>
<DICH_DATA CI_END="1.0444974973385885" CI_START="0.3446633437775495" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="25" LOG_CI_END="0.01890740372911514" LOG_CI_START="-0.4626049029618279" LOG_EFFECT_SIZE="-0.22184874961635637" ORDER="85" O_E="0.0" SE="0.282842712474619" STUDY_ID="STD-Dimitriou-2000" TOTAL_1="75" TOTAL_2="75" VAR="0.07999999999999999" WEIGHT="25.20119501979788"/>
<DICH_DATA CI_END="1.1908760601251096" CI_START="0.004968745246832799" EFFECT_SIZE="0.07692307692307693" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="6" LOG_CI_END="0.07586656483740845" LOG_CI_START="-2.303753269451082" LOG_EFFECT_SIZE="-1.1139433523068367" ORDER="86" O_E="0.0" SE="1.3978004699692133" STUDY_ID="STD-Engelke-1982" TOTAL_1="9" TOTAL_2="9" VAR="1.9538461538461536" WEIGHT="6.552310705147448"/>
<DICH_DATA CI_END="0.8148735481416008" CI_START="0.11618312611684649" EFFECT_SIZE="0.3076923076923077" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="13" LOG_CI_END="-0.08890977973258553" LOG_CI_START="-0.934856942225163" LOG_EFFECT_SIZE="-0.5118833609788743" ORDER="87" O_E="0.0" SE="0.49691355075412963" STUDY_ID="STD-So-1995" TOTAL_1="25" TOTAL_2="25" VAR="0.24692307692307694" WEIGHT="13.104621410294897"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.86406019136236" CI_END="1.503373498053273" CI_START="0.9092300296921393" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1691502599210046" ESTIMABLE="YES" EVENTS_1="78" EVENTS_2="66" I2="38.32313166421284" I2_Q="0.0" ID="CMP-003.02" LOG_CI_END="0.17706689009614088" LOG_CI_START="-0.04132622900269985" LOG_EFFECT_SIZE="0.06787033054672051" METHOD="MH" NO="2" P_CHI2="0.1820264066857128" P_Q="0.0" P_Z="0.22314746431923294" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="184" TOTAL_2="183" WEIGHT="100.0" Z="1.2182014162286583">
<NAME>Oxygen use at 28 days</NAME>
<GROUP_LABEL_1>NCPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>Headbox</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NCPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Headbox</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.3121500097843388" CI_START="0.4726260300847211" EFFECT_SIZE="0.7875" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="20" LOG_CI_END="0.11798348801023986" LOG_CI_START="-0.32548236308696366" LOG_EFFECT_SIZE="-0.1037494375383619" ORDER="88" O_E="0.0" SE="0.26049403612586386" STUDY_ID="STD-Annibale-1994" TOTAL_1="40" TOTAL_2="42" VAR="0.06785714285714287" WEIGHT="29.482282448937116"/>
<DICH_DATA CI_END="2.0444198233334254" CI_START="0.9223614383479078" EFFECT_SIZE="1.3732057416267942" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="19" LOG_CI_END="0.3105700833586155" LOG_CI_START="-0.03509886211273891" LOG_EFFECT_SIZE="0.13773561062293832" ORDER="89" O_E="0.0" SE="0.20304764965874977" STUDY_ID="STD-Davis-1998" TOTAL_1="44" TOTAL_2="41" VAR="0.041228348031942384" WEIGHT="29.721609212346138"/>
<DICH_DATA CI_END="2.2549339822400922" CI_START="0.9382547320685042" EFFECT_SIZE="1.4545454545454546" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="22" LOG_CI_END="0.3531338315494408" LOG_CI_START="-0.02767923655404132" LOG_EFFECT_SIZE="0.16272729749769974" ORDER="90" O_E="0.0" SE="0.2236914812590743" STUDY_ID="STD-Dimitriou-2000" TOTAL_1="75" TOTAL_2="75" VAR="0.050037878787878784" WEIGHT="33.2412734611766"/>
<DICH_DATA CI_END="2.2452542631126713" CI_START="0.160338187934635" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.35126552966630087" LOG_CI_START="-0.7949630288990137" LOG_EFFECT_SIZE="-0.22184874961635637" ORDER="91" O_E="0.0" SE="0.6733003292241385" STUDY_ID="STD-So-1995" TOTAL_1="25" TOTAL_2="25" VAR="0.45333333333333337" WEIGHT="7.554834877540136"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" NO="4">
<NAME>Nasal CPAP vs Headbox (extubation &gt; 14 days of age)</NAME>
<DICH_OUTCOME CHI2="0.5182942672669975" CI_END="2.149334526580885" CI_START="0.5848864405266772" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1212121212121213" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="12" I2="0.0" I2_Q="0.0" ID="CMP-004.01" LOG_CI_END="0.3323040151850099" LOG_CI_START="-0.23292844680679473" LOG_EFFECT_SIZE="0.04968778418910756" METHOD="MH" NO="1" P_CHI2="0.47157027318365197" P_Q="0.0" P_Z="0.7304038479579545" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="32" TOTAL_2="34" WEIGHT="100.00000000000001" Z="0.3445883739199026">
<NAME>Failure</NAME>
<GROUP_LABEL_1>NCPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>Headbox</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NCPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Headbox</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.5136849155397565" CI_START="0.5942778075561082" EFFECT_SIZE="1.2222222222222223" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="9" LOG_CI_END="0.40031083897511427" LOG_CI_START="-0.2260104875373139" LOG_EFFECT_SIZE="0.0871501757189002" ORDER="92" O_E="0.0" SE="0.3679042475339682" STUDY_ID="STD-Chan-1993" TOTAL_1="30" TOTAL_2="30" VAR="0.13535353535353536" WEIGHT="81.81818181818183"/>
<DICH_DATA CI_END="2.978685547154268" CI_START="0.149208245519253" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4740246581852024" LOG_CI_START="-0.8262071762965648" LOG_EFFECT_SIZE="-0.17609125905568127" ORDER="93" O_E="0.0" SE="0.7637626158259733" STUDY_ID="STD-Davis-1998" TOTAL_1="2" TOTAL_2="4" VAR="0.5833333333333333" WEIGHT="18.181818181818183"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" NO="5">
<NAME>Nasal CPAP vs Headbox (CPAP &lt; 5cm water)</NAME>
<DICH_OUTCOME CHI2="3.3425231142748175" CI_END="1.7336427810753472" CI_START="0.6850887611444432" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0898161244695899" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="24" I2="70.08248063478368" I2_Q="0.0" ID="CMP-005.01" LOG_CI_END="0.23895961552202186" LOG_CI_START="-0.16425315700694432" LOG_EFFECT_SIZE="0.03735322925753873" METHOD="MH" NO="1" P_CHI2="0.06751108922046067" P_Q="0.0" P_Z="0.7165016365707604" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="89" TOTAL_2="90" WEIGHT="100.0" Z="0.36313821901950977">
<NAME>Failure</NAME>
<GROUP_LABEL_1>NCPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>Headbox</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NCPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Headbox</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.422107786431701" CI_START="0.5244804758903293" EFFECT_SIZE="0.8636363636363636" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="22" LOG_CI_END="0.1529325143111046" LOG_CI_START="-0.2802706740498591" LOG_EFFECT_SIZE="-0.06366907986937727" ORDER="94" O_E="0.0" SE="0.2544656972335968" STUDY_ID="STD-Chan-1993" TOTAL_1="60" TOTAL_2="60" VAR="0.06475279106858055" WEIGHT="91.7963224893918"/>
<DICH_DATA CI_END="16.005522978132642" CI_START="0.8190543724802425" EFFECT_SIZE="3.6206896551724137" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="2" LOG_CI_END="1.2042698692209484" LOG_CI_START="-0.08668726687898436" LOG_EFFECT_SIZE="0.558791301170982" ORDER="95" O_E="0.0" SE="0.7583146120859863" STUDY_ID="STD-Tapia-1995" TOTAL_1="29" TOTAL_2="30" VAR="0.5750410509031199" WEIGHT="8.203677510608205"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-006" NO="6">
<NAME>Nasal CPAP vs Headbox (CPAP &gt; or = 5 cm water)</NAME>
<DICH_OUTCOME CHI2="10.229599458752109" CI_END="0.6569478446529673" CI_START="0.366314794583697" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.49056061273430235" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="86" I2="60.89778474583645" I2_Q="0.0" ID="CMP-006.01" LOG_CI_END="-0.18246910788089105" LOG_CI_START="-0.4361455408595869" LOG_EFFECT_SIZE="-0.309307324370239" METHOD="MH" NO="1" P_CHI2="0.036732734295165326" P_Q="0.0" P_Z="1.7567682946178477E-6" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="150" TOTAL_2="150" WEIGHT="100.0" Z="4.779562758760715">
<NAME>Failure</NAME>
<GROUP_LABEL_1>NCPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>Headbox</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NCPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Headbox</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.5941904334831003" CI_START="0.5384223445562102" EFFECT_SIZE="0.9264705882352942" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="17" LOG_CI_END="0.20254019866045836" LOG_CI_START="-0.26887692516576756" LOG_EFFECT_SIZE="-0.0331683632526546" ORDER="96" O_E="0.0" SE="0.2769127520879231" STUDY_ID="STD-Annibale-1994" TOTAL_1="40" TOTAL_2="42" VAR="0.07668067226890757" WEIGHT="19.135711838692313"/>
<DICH_DATA CI_END="0.9023409125657522" CI_START="0.35675584707168095" EFFECT_SIZE="0.5673758865248227" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="27" LOG_CI_END="-0.04462935106774575" LOG_CI_START="-0.4476289002591268" LOG_EFFECT_SIZE="-0.24612912566343625" ORDER="97" O_E="0.0" SE="0.23672393007495873" STUDY_ID="STD-Davis-1998" TOTAL_1="47" TOTAL_2="45" VAR="0.056038219070133954" WEIGHT="31.829026574658638"/>
<DICH_DATA CI_END="1.1908760601251096" CI_START="0.004968745246832799" EFFECT_SIZE="0.07692307692307693" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="6" LOG_CI_END="0.07586656483740845" LOG_CI_START="-2.303753269451082" LOG_EFFECT_SIZE="-1.1139433523068367" ORDER="98" O_E="0.0" SE="1.3978004699692133" STUDY_ID="STD-Engelke-1982" TOTAL_1="9" TOTAL_2="9" VAR="1.9538461538461536" WEIGHT="7.499510595605148"/>
<DICH_DATA CI_END="0.5956426655046728" CI_START="0.15550867089981768" EFFECT_SIZE="0.30434782608695654" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="23" LOG_CI_END="-0.2250142015686075" LOG_CI_START="-0.8082453904380645" LOG_EFFECT_SIZE="-0.516629796003336" ORDER="99" O_E="0.0" SE="0.34259288738286553" STUDY_ID="STD-Higgins-1991" TOTAL_1="29" TOTAL_2="29" VAR="0.11736988648532877" WEIGHT="26.5367297998336"/>
<DICH_DATA CI_END="0.8148735481416008" CI_START="0.11618312611684649" EFFECT_SIZE="0.3076923076923077" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="13" LOG_CI_END="-0.08890977973258553" LOG_CI_START="-0.934856942225163" LOG_EFFECT_SIZE="-0.5118833609788743" ORDER="100" O_E="0.0" SE="0.49691355075412963" STUDY_ID="STD-So-1995" TOTAL_1="25" TOTAL_2="25" VAR="0.24692307692307694" WEIGHT="14.999021191210296"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="9.281291356825376" CI_END="1.1017242480717815" CI_START="0.6710551738226768" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8598358894547652" ESTIMABLE="YES" EVENTS_1="60" EVENTS_2="70" I2="67.6769117069703" I2_Q="0.0" ID="CMP-006.02" LOG_CI_END="0.042072908012426" LOG_CI_START="-0.17324177088667403" LOG_EFFECT_SIZE="-0.06558443143712402" METHOD="MH" NO="2" P_CHI2="0.025775623058820862" P_Q="0.0" P_Z="0.23247704394243085" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="141" TOTAL_2="142" WEIGHT="100.00000000000001" Z="1.1940024174899564">
<NAME>Oxygen use at 28 days</NAME>
<GROUP_LABEL_1>NCPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>Headbox</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NCPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Headbox</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.3121500097843388" CI_START="0.4726260300847211" EFFECT_SIZE="0.7875" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="20" LOG_CI_END="0.11798348801023986" LOG_CI_START="-0.32548236308696366" LOG_EFFECT_SIZE="-0.1037494375383619" ORDER="101" O_E="0.0" SE="0.26049403612586386" STUDY_ID="STD-Annibale-1994" TOTAL_1="40" TOTAL_2="42" VAR="0.06785714285714287" WEIGHT="28.018936527017203"/>
<DICH_DATA CI_END="1.8347635475341042" CI_START="0.9076468905816681" EFFECT_SIZE="1.2904717853839038" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="23" LOG_CI_END="0.2635801031287629" LOG_CI_START="-0.042083075816150846" LOG_EFFECT_SIZE="0.11074851365630602" ORDER="102" O_E="0.0" SE="0.1795480643693804" STUDY_ID="STD-Davis-1998" TOTAL_1="47" TOTAL_2="45" VAR="0.03223750741879117" WEIGHT="33.74530667972634"/>
<DICH_DATA CI_END="0.8640747711677105" CI_START="0.30962441376377225" EFFECT_SIZE="0.5172413793103449" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="22" LOG_CI_END="-0.06344867499735926" LOG_CI_START="-0.5091648026891904" LOG_EFFECT_SIZE="-0.2863067388432748" ORDER="103" O_E="0.0" SE="0.2618158597365969" STUDY_ID="STD-Higgins-1991" TOTAL_1="29" TOTAL_2="30" VAR="0.06854754440961336" WEIGHT="31.055904308208305"/>
<DICH_DATA CI_END="2.2452542631126713" CI_START="0.160338187934635" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.35126552966630087" LOG_CI_START="-0.7949630288990137" LOG_EFFECT_SIZE="-0.22184874961635637" ORDER="104" O_E="0.0" SE="0.6733003292241385" STUDY_ID="STD-So-1995" TOTAL_1="25" TOTAL_2="25" VAR="0.45333333333333337" WEIGHT="7.179852485048158"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-007" NO="7">
<NAME>Nasal CPAP vs Headbox (trials allowing rescue CPAP)</NAME>
<DICH_OUTCOME CHI2="4.199934447924008" CI_END="1.5336941171073164" CI_START="0.7006507216588209" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0366213821618429" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="36" I2="28.570313722804062" I2_Q="0.0" ID="CMP-007.01" LOG_CI_END="0.18573875172588467" LOG_CI_START="-0.1544984263400694" LOG_EFFECT_SIZE="0.01562016269290763" METHOD="MH" NO="1" P_CHI2="0.24066858683603165" P_Q="0.0" P_Z="0.8571820556265924" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="160" TOTAL_2="158" WEIGHT="100.0" Z="0.17996243964156386">
<NAME>Endotracheal reintubation</NAME>
<GROUP_LABEL_1>NCPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>Headbox</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NCPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Headbox</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.9727680138280648" CI_START="0.6069280198871702" EFFECT_SIZE="1.094224924012158" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="14" LOG_CI_END="0.2950760177215547" LOG_CI_START="-0.21686281208692879" LOG_EFFECT_SIZE="0.039106602817312944" ORDER="105" O_E="0.0" SE="0.3007154027675808" STUDY_ID="STD-Davis-1998" TOTAL_1="47" TOTAL_2="45" VAR="0.09042975346166834" WEIGHT="38.86591848789132"/>
<DICH_DATA CI_END="3.5705608027685374" CI_START="0.7779668044369803" EFFECT_SIZE="1.6666666666666667" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="9" LOG_CI_END="0.5527364330366169" LOG_CI_START="-0.1090389338039041" LOG_EFFECT_SIZE="0.22184874961635637" ORDER="106" O_E="0.0" SE="0.38873012632302" STUDY_ID="STD-Dimitriou-2000" TOTAL_1="75" TOTAL_2="75" VAR="0.15111111111111108" WEIGHT="24.453632604843474"/>
<DICH_DATA CI_END="3.6607149685994704" CI_START="0.01092682722995594" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5635659150646828" LOG_CI_START="-1.9615059237367205" LOG_EFFECT_SIZE="-0.6989700043360187" ORDER="107" O_E="0.0" SE="1.4832396974191324" STUDY_ID="STD-Engelke-1982" TOTAL_1="9" TOTAL_2="9" VAR="2.1999999999999997" WEIGHT="6.792675723567632"/>
<DICH_DATA CI_END="1.410120390358691" CI_START="0.2871802155721906" EFFECT_SIZE="0.6363636363636364" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="11" LOG_CI_END="0.14925619253939076" LOG_CI_START="-0.5418454828273271" LOG_EFFECT_SIZE="-0.19629464514396822" ORDER="108" O_E="0.0" SE="0.4059565451188765" STUDY_ID="STD-Higgins-1991" TOTAL_1="29" TOTAL_2="29" VAR="0.16480071652485445" WEIGHT="29.88777318369758"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-008" NO="8">
<NAME>Nasal CPAP vs Headbox (excluding quasi-randomised trial of Tapia)</NAME>
<DICH_OUTCOME CHI2="12.736604958555674" CI_END="0.7194772672745242" CI_START="0.4753492516802926" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5848102090421532" ESTIMABLE="YES" EVENTS_1="92" EVENTS_2="157" I2="45.04029902177482" I2_Q="0.0" ID="CMP-008.01" LOG_CI_END="-0.1429829235525335" LOG_CI_START="-0.32298718544261706" LOG_EFFECT_SIZE="-0.23298505449757528" METHOD="MH" NO="1" P_CHI2="0.0787920447717767" P_Q="0.0" P_Z="3.901880937001688E-7" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="334" TOTAL_2="333" WEIGHT="100.0" Z="5.073683377899019">
<NAME>Failure</NAME>
<GROUP_LABEL_1>NCPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>Headbox</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NCPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Headbox</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.5941904334831003" CI_START="0.5384223445562102" EFFECT_SIZE="0.9264705882352942" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="17" LOG_CI_END="0.20254019866045836" LOG_CI_START="-0.26887692516576756" LOG_EFFECT_SIZE="-0.0331683632526546" ORDER="109" O_E="0.0" SE="0.2769127520879231" STUDY_ID="STD-Annibale-1994" TOTAL_1="40" TOTAL_2="42" VAR="0.07668067226890757" WEIGHT="10.502401614058549"/>
<DICH_DATA CI_END="1.422107786431701" CI_START="0.5244804758903293" EFFECT_SIZE="0.8636363636363636" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="22" LOG_CI_END="0.1529325143111046" LOG_CI_START="-0.2802706740498591" LOG_EFFECT_SIZE="-0.06366907986937727" ORDER="110" O_E="0.0" SE="0.2544656972335968" STUDY_ID="STD-Chan-1993" TOTAL_1="60" TOTAL_2="60" VAR="0.06475279106858055" WEIGHT="13.931126846883545"/>
<DICH_DATA CI_END="0.9023409125657522" CI_START="0.35675584707168095" EFFECT_SIZE="0.5673758865248227" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="27" LOG_CI_END="-0.04462935106774575" LOG_CI_START="-0.4476289002591268" LOG_EFFECT_SIZE="-0.24612912566343625" ORDER="111" O_E="0.0" SE="0.23672393007495873" STUDY_ID="STD-Davis-1998" TOTAL_1="47" TOTAL_2="45" VAR="0.056038219070133954" WEIGHT="17.468972301082232"/>
<DICH_DATA CI_END="1.0444974973385885" CI_START="0.3446633437775495" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="25" LOG_CI_END="0.01890740372911514" LOG_CI_START="-0.4626049029618279" LOG_EFFECT_SIZE="-0.22184874961635637" ORDER="112" O_E="0.0" SE="0.282842712474619" STUDY_ID="STD-Dimitriou-2000" TOTAL_1="75" TOTAL_2="75" VAR="0.07999999999999999" WEIGHT="15.830825962367664"/>
<DICH_DATA CI_END="1.1908760601251096" CI_START="0.004968745246832799" EFFECT_SIZE="0.07692307692307693" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="6" LOG_CI_END="0.07586656483740845" LOG_CI_START="-2.303753269451082" LOG_EFFECT_SIZE="-1.1139433523068367" ORDER="113" O_E="0.0" SE="1.3978004699692133" STUDY_ID="STD-Engelke-1982" TOTAL_1="9" TOTAL_2="9" VAR="1.9538461538461536" WEIGHT="4.116014750215593"/>
<DICH_DATA CI_END="0.5956426655046728" CI_START="0.15550867089981768" EFFECT_SIZE="0.30434782608695654" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="23" LOG_CI_END="-0.2250142015686075" LOG_CI_START="-0.8082453904380645" LOG_EFFECT_SIZE="-0.516629796003336" ORDER="114" O_E="0.0" SE="0.34259288738286553" STUDY_ID="STD-Higgins-1991" TOTAL_1="29" TOTAL_2="29" VAR="0.11736988648532877" WEIGHT="14.564359885378252"/>
<DICH_DATA CI_END="1.0677679183951514" CI_START="0.39942103109177673" EFFECT_SIZE="0.6530612244897959" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="24" LOG_CI_END="0.02847686812962176" LOG_CI_START="-0.3985690715468373" LOG_EFFECT_SIZE="-0.18504610170860772" ORDER="115" O_E="0.0" SE="0.25084889887744616" STUDY_ID="STD-Peake-2005" TOTAL_1="49" TOTAL_2="48" VAR="0.06292517006802721" WEIGHT="15.354269139582987"/>
<DICH_DATA CI_END="0.8148735481416008" CI_START="0.11618312611684649" EFFECT_SIZE="0.3076923076923077" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="13" LOG_CI_END="-0.08890977973258553" LOG_CI_START="-0.934856942225163" LOG_EFFECT_SIZE="-0.5118833609788743" ORDER="116" O_E="0.0" SE="0.49691355075412963" STUDY_ID="STD-So-1995" TOTAL_1="25" TOTAL_2="25" VAR="0.24692307692307694" WEIGHT="8.232029500431185"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="12.574441411648946" CI_END="1.243905875153208" CI_START="0.808119329222671" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0026087878354897" ESTIMABLE="YES" EVENTS_1="92" EVENTS_2="92" I2="68.18944182845048" I2_Q="0.0" ID="CMP-008.02" LOG_CI_END="0.09478751906209623" LOG_CI_START="-0.09252450531884773" LOG_EFFECT_SIZE="0.00113150687162424" METHOD="MH" NO="2" P_CHI2="0.013553676825787009" P_Q="0.0" P_Z="0.9811083843044289" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="217" TOTAL_2="218" WEIGHT="100.0" Z="0.0236793417184243">
<NAME>Oxygen use at 28 days</NAME>
<GROUP_LABEL_1>NCPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>Headbox</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NCPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Headbox</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.3121500097843388" CI_START="0.4726260300847211" EFFECT_SIZE="0.7875" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="20" LOG_CI_END="0.11798348801023986" LOG_CI_START="-0.32548236308696366" LOG_EFFECT_SIZE="-0.1037494375383619" ORDER="117" O_E="0.0" SE="0.26049403612586386" STUDY_ID="STD-Annibale-1994" TOTAL_1="40" TOTAL_2="42" VAR="0.06785714285714287" WEIGHT="21.292384589185545"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="118" O_E="0.0" SE="0.0" STUDY_ID="STD-Chan-1993" TOTAL_1="1" TOTAL_2="1" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.8347635475341042" CI_START="0.9076468905816681" EFFECT_SIZE="1.2904717853839038" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="23" LOG_CI_END="0.2635801031287629" LOG_CI_START="-0.042083075816150846" LOG_EFFECT_SIZE="0.11074851365630602" ORDER="119" O_E="0.0" SE="0.1795480643693804" STUDY_ID="STD-Davis-1998" TOTAL_1="47" TOTAL_2="45" VAR="0.03223750741879117" WEIGHT="25.64401568960034"/>
<DICH_DATA CI_END="2.2549339822400922" CI_START="0.9382547320685042" EFFECT_SIZE="1.4545454545454546" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="22" LOG_CI_END="0.3531338315494408" LOG_CI_START="-0.02767923655404132" LOG_EFFECT_SIZE="0.16272729749769974" ORDER="120" O_E="0.0" SE="0.2236914812590743" STUDY_ID="STD-Dimitriou-2000" TOTAL_1="75" TOTAL_2="75" VAR="0.050037878787878784" WEIGHT="24.0071636243067"/>
<DICH_DATA CI_END="0.8640747711677105" CI_START="0.30962441376377225" EFFECT_SIZE="0.5172413793103449" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="22" LOG_CI_END="-0.06344867499735926" LOG_CI_START="-0.5091648026891904" LOG_EFFECT_SIZE="-0.2863067388432748" ORDER="121" O_E="0.0" SE="0.2618158597365969" STUDY_ID="STD-Higgins-1991" TOTAL_1="29" TOTAL_2="30" VAR="0.06854754440961336" WEIGHT="23.60026254592862"/>
<DICH_DATA CI_END="2.2452542631126713" CI_START="0.160338187934635" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.35126552966630087" LOG_CI_START="-0.7949630288990137" LOG_EFFECT_SIZE="-0.22184874961635637" ORDER="122" O_E="0.0" SE="0.6733003292241385" STUDY_ID="STD-So-1995" TOTAL_1="25" TOTAL_2="25" VAR="0.45333333333333337" WEIGHT="5.456173550978796"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-009" NO="9">
<NAME>Nasal CPAP vs Headbox (weight &lt; 2000g)</NAME>
<DICH_OUTCOME CHI2="15.516687257047273" CI_END="0.8142918989148626" CI_START="0.5253536055043928" CI_STUDY="95" CI_TOTAL="95" DF="6.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6540574783823985" ESTIMABLE="YES" EVENTS_1="84" EVENTS_2="128" I2="61.33195249343601" I2_Q="0.0" ID="CMP-009.01" LOG_CI_END="-0.08921988581882125" LOG_CI_START="-0.27954828283104893" LOG_EFFECT_SIZE="-0.18438408432493508" METHOD="MH" NO="1" P_CHI2="0.016597152199849585" P_Q="0.0" P_Z="1.4616202861536399E-4" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="279" TOTAL_2="279" WEIGHT="100.00000000000001" Z="3.7975012690938796">
<NAME>Failure</NAME>
<GROUP_LABEL_1>NCPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>Headbox</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NCPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Headbox</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.5941904334831003" CI_START="0.5384223445562102" EFFECT_SIZE="0.9264705882352942" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="17" LOG_CI_END="0.20254019866045836" LOG_CI_START="-0.26887692516576756" LOG_EFFECT_SIZE="-0.0331683632526546" ORDER="123" O_E="0.0" SE="0.2769127520879231" STUDY_ID="STD-Annibale-1994" TOTAL_1="40" TOTAL_2="42" VAR="0.07668067226890757" WEIGHT="12.9183755635158"/>
<DICH_DATA CI_END="1.422107786431701" CI_START="0.5244804758903293" EFFECT_SIZE="0.8636363636363636" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="22" LOG_CI_END="0.1529325143111046" LOG_CI_START="-0.2802706740498591" LOG_EFFECT_SIZE="-0.06366907986937727" ORDER="124" O_E="0.0" SE="0.2544656972335968" STUDY_ID="STD-Chan-1993" TOTAL_1="60" TOTAL_2="60" VAR="0.06475279106858055" WEIGHT="17.13584523278125"/>
<DICH_DATA CI_END="0.9023409125657522" CI_START="0.35675584707168095" EFFECT_SIZE="0.5673758865248227" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="27" LOG_CI_END="-0.04462935106774575" LOG_CI_START="-0.4476289002591268" LOG_EFFECT_SIZE="-0.24612912566343625" ORDER="125" O_E="0.0" SE="0.23672393007495873" STUDY_ID="STD-Davis-1998" TOTAL_1="47" TOTAL_2="45" VAR="0.056038219070133954" WEIGHT="21.487537154544867"/>
<DICH_DATA CI_END="0.5956426655046728" CI_START="0.15550867089981768" EFFECT_SIZE="0.30434782608695654" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="23" LOG_CI_END="-0.2250142015686075" LOG_CI_START="-0.8082453904380645" LOG_EFFECT_SIZE="-0.516629796003336" ORDER="126" O_E="0.0" SE="0.34259288738286553" STUDY_ID="STD-Higgins-1991" TOTAL_1="29" TOTAL_2="29" VAR="0.11736988648532877" WEIGHT="17.914747288816763"/>
<DICH_DATA CI_END="1.0677679183951514" CI_START="0.39942103109177673" EFFECT_SIZE="0.6530612244897959" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="24" LOG_CI_END="0.02847686812962176" LOG_CI_START="-0.3985690715468373" LOG_EFFECT_SIZE="-0.18504610170860772" ORDER="127" O_E="0.0" SE="0.25084889887744616" STUDY_ID="STD-Peake-2005" TOTAL_1="49" TOTAL_2="48" VAR="0.06292517006802721" WEIGHT="18.886367379335287"/>
<DICH_DATA CI_END="0.8148735481416008" CI_START="0.11618312611684649" EFFECT_SIZE="0.3076923076923077" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="13" LOG_CI_END="-0.08890977973258553" LOG_CI_START="-0.934856942225163" LOG_EFFECT_SIZE="-0.5118833609788743" ORDER="128" O_E="0.0" SE="0.49691355075412963" STUDY_ID="STD-So-1995" TOTAL_1="25" TOTAL_2="25" VAR="0.24692307692307694" WEIGHT="10.125726728461649"/>
<DICH_DATA CI_END="16.005522978132642" CI_START="0.8190543724802425" EFFECT_SIZE="3.6206896551724137" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="2" LOG_CI_END="1.2042698692209484" LOG_CI_START="-0.08668726687898436" LOG_EFFECT_SIZE="0.558791301170982" ORDER="129" O_E="0.0" SE="0.7583146120859863" STUDY_ID="STD-Tapia-1995" TOTAL_1="29" TOTAL_2="30" VAR="0.5750410509031199" WEIGHT="1.5314006525443955"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="9.281291356825376" CI_END="1.1017242480717815" CI_START="0.6710551738226768" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8598358894547652" ESTIMABLE="YES" EVENTS_1="60" EVENTS_2="70" I2="67.6769117069703" I2_Q="0.0" ID="CMP-009.02" LOG_CI_END="0.042072908012426" LOG_CI_START="-0.17324177088667403" LOG_EFFECT_SIZE="-0.06558443143712402" METHOD="MH" NO="2" P_CHI2="0.025775623058820862" P_Q="0.0" P_Z="0.23247704394243085" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="141" TOTAL_2="142" WEIGHT="100.00000000000001" Z="1.1940024174899564">
<NAME>Oxygen use at 28 days</NAME>
<GROUP_LABEL_1>NCPAP</GROUP_LABEL_1>
<GROUP_LABEL_2>Headbox</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NCPAP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Headbox</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.3121500097843388" CI_START="0.4726260300847211" EFFECT_SIZE="0.7875" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="20" LOG_CI_END="0.11798348801023986" LOG_CI_START="-0.32548236308696366" LOG_EFFECT_SIZE="-0.1037494375383619" ORDER="130" O_E="0.0" SE="0.26049403612586386" STUDY_ID="STD-Annibale-1994" TOTAL_1="40" TOTAL_2="42" VAR="0.06785714285714287" WEIGHT="28.018936527017203"/>
<DICH_DATA CI_END="1.8347635475341042" CI_START="0.9076468905816681" EFFECT_SIZE="1.2904717853839038" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="23" LOG_CI_END="0.2635801031287629" LOG_CI_START="-0.042083075816150846" LOG_EFFECT_SIZE="0.11074851365630602" ORDER="131" O_E="0.0" SE="0.1795480643693804" STUDY_ID="STD-Davis-1998" TOTAL_1="47" TOTAL_2="45" VAR="0.03223750741879117" WEIGHT="33.74530667972634"/>
<DICH_DATA CI_END="0.8640747711677105" CI_START="0.30962441376377225" EFFECT_SIZE="0.5172413793103449" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="22" LOG_CI_END="-0.06344867499735926" LOG_CI_START="-0.5091648026891904" LOG_EFFECT_SIZE="-0.2863067388432748" ORDER="132" O_E="0.0" SE="0.2618158597365969" STUDY_ID="STD-Higgins-1991" TOTAL_1="29" TOTAL_2="30" VAR="0.06854754440961336" WEIGHT="31.055904308208305"/>
<DICH_DATA CI_END="2.2452542631126713" CI_START="0.160338187934635" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.35126552966630087" LOG_CI_START="-0.7949630288990137" LOG_EFFECT_SIZE="-0.22184874961635637" ORDER="133" O_E="0.0" SE="0.6733003292241385" STUDY_ID="STD-So-1995" TOTAL_1="25" TOTAL_2="25" VAR="0.45333333333333337" WEIGHT="7.179852485048158"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES/>
<FEEDBACK/>
<APPENDICES/>
<EXTENSIONS/>
</COCHRANE_REVIEW>